US20040059263A1 - Device and method for measuring the diameter of an air passageway - Google Patents

Device and method for measuring the diameter of an air passageway Download PDF

Info

Publication number
US20040059263A1
US20040059263A1 US10/254,392 US25439202A US2004059263A1 US 20040059263 A1 US20040059263 A1 US 20040059263A1 US 25439202 A US25439202 A US 25439202A US 2004059263 A1 US2004059263 A1 US 2004059263A1
Authority
US
United States
Prior art keywords
air passageway
transverse dimension
expandable member
fluid
changeable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/254,392
Inventor
Lauri DeVore
William Sirokman
James Kutsko
David Dillard
Peter Westman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gyrus ACMI Inc
Original Assignee
Spiration Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spiration Inc filed Critical Spiration Inc
Priority to US10/254,392 priority Critical patent/US20040059263A1/en
Assigned to SPIRATION, INC. reassignment SPIRATION, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DILLARD, DAVID H., WESTMAN, PETER R., KUTSKO, JAMES M., SIROKMAN, WILLIAM A., DEVORE, LAURI J.
Priority to PCT/US2003/021901 priority patent/WO2004006767A2/en
Priority to AU2003249202A priority patent/AU2003249202A1/en
Publication of US20040059263A1 publication Critical patent/US20040059263A1/en
Priority to US11/260,012 priority patent/US7476203B2/en
Assigned to GYRUS ACMI, INC. reassignment GYRUS ACMI, INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: SPIRATION, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • A61B5/1076Measuring physical dimensions, e.g. size of the entire body or parts thereof for measuring dimensions inside body cavities, e.g. using catheters

Definitions

  • the present invention is generally directed to a device and method for measuring the inside diameter of a body lumen and, more particularly, of air passageways.
  • the present invention is more particularly directed toward measuring an inside diameter of an air passageway by transorally inserting a balloon having a known volume-to-diameter relationship in the air passageway, expanding the balloon with a volume of fluid to a known transverse diameter, and determining that the transverse diameter is adjacent to opposing portions of an interior wall of the air passageway.
  • COPD Chronic Obstructive Pulmonary Disease
  • the performance of intra-bronchial devices may be enhanced by sizing the device to fit the air passageway.
  • the invention provides a device for measuring an inside diameter of a body lumen, such as an air passageway.
  • the device includes a flexible catheter, and a member carried on a distal tip of the catheter, the member having a known transverse dimension and arranged for placement adjacent to opposing portions of an interior wall of the air passageway.
  • the invention further provides a device for measuring the diameter of an air passageway.
  • the device includes a flexible catheter having an inflation lumen, a fluid dispenser in fluid communication with the inflation lumen and operable to communicate a measurable fluid volume change with the inflation lumen, and an expandable member in fluid communication with the inflation lumen and having a known relationship between fluid volume and a changeable transverse dimension, the transverse dimension being changeable in response to fluid volume changes of the fluid dispenser and arranged for placement adjacent to opposing portions of an interior wall of the air passageway.
  • the expandable member may include a balloon of compliant material. The expandable member may be dimensioned for transoral placement into the air passageway.
  • the expandable member may have a collapsed configuration for placement in the air passageway and an expanded configuration for measuring a diameter of the air passageway.
  • the expandable member may be arranged to transition from an expanded configuration to a collapsed configuration while in the air passageway, and then to transition from the collapsed configuration to a re-expanded configuration for measuring the diameter of another air passageway.
  • the catheter may include configuration to be steerable within bronchi.
  • the catheter may include an expansion lumen and a purge lumen.
  • the transverse dimension of the expandable member may be arranged to have a maximum transverse dimension of between 3 mm and 12 mm.
  • the fluid dispenser may comprise a syringe or a syringe pump, and may further include gradations corresponding to air passageway diameters.
  • the fluid dispenser may include a piston and a proximal portion of the inflation lumen cooperatively acting as a piston/cylinder combination arranged to communicate a measurable fluid volume change with another portion of the inflation lumen in communication with the expandable member.
  • the fluid communicated to the expandable member may include a radiopaque contrast substance.
  • the expandable member may include a radiopaque contrast marker arranged for visualization of the changeable transverse dimension by fluoroscopy.
  • the catheter may have a distal end, and the expandable member may be carried on the catheter proximal to the distal end.
  • the device may further include a visualization device for observing adjacency of the transverse dimension and opposing portions of the interior wall of the air passageway.
  • the visualization device may include a bronchoscope or a fluoroscope.
  • the invention still further provides an assembly for measuring an inside diameter of an air passageway.
  • the assembly includes a flexible catheter having an inflation lumen, the inflation lumen being arranged for fluid coupling with a fluid dispenser operable to communicate a measurable fluid volume change with the inflation lumen, and an expandable member in fluid communication with the inflation lumen and having a known relationship between fluid volume and a changeable transverse dimension, the transverse dimension of the expandable member being changeable in response to fluid volume changes of the fluid dispenser and arranged for placement adjacent to opposing portions of an interior wall of the air passageway.
  • the expandable member may be carried on the catheter.
  • the catheter may have a distal end, and the expandable member may be carried proximate to the distal end of the catheter.
  • the expandable member may comprise a complaint material, and may be a balloon.
  • the assembly may further include a visualization device for observing adjacency of the transverse dimension and opposing portions of the interior wall of the air passageway.
  • the visualization device may include a bronchoscope or a fluoroscope.
  • the invention also provides a method of measuring an air passageway diameter.
  • the method includes the steps of placing a balloon member in the air passageway having a known transverse dimension, and determining that the known transverse dimension is adjacent to opposing portions of an inner periphery of the air passageway.
  • the method includes the steps of placing an expandable member in the air passageway, the expandable member changeable in a transverse dimension and having a known relationship between fluid volume and changeable transverse dimension, changing the changeable transverse dimension of the expandable member to a known transverse dimension by changing the fluid volume of the expandable member, and determining that the known expanded transverse dimension is adjacent to opposing portions of an inner periphery of the air passageway.
  • the method may include the further step of placing a fluid dispenser operable to communicate a measurable fluid volume change into fluid communication with the expandable member, and the step of changing to a known transverse dimension includes the further step of measurably changing the volume of fluid in the expandable member with the fluid dispenser.
  • the fluid dispenser may comprise a syringe.
  • the fluid dispenser may include gradations related to air passageway diameter, and the step of determining air passageway diameter may include the further step of observing the gradations.
  • the step of placing an expandable member in the air passageway may include the further step of transorally placing the expandable member in the air passageway.
  • the step of determining may include the further step of visually observing adjacency, which may include using a visualization device or a fluoroscope.
  • the expandable member may include a radiopaque contrast substance arranged to enhance viewing the changeable transverse dimension, and the step of determining adjacency may use fluoroscopy.
  • the expandable member may include a balloon of compliant material.
  • the invention further provides a device for measuring an inside diameter of a body lumen is provided.
  • the device includes means for placing an expandable member having a known transverse dimension in the air passageway, and means for determining that the known transverse dimension is adjacent to opposing portions of an inner periphery of the air passageway.
  • the invention still further provides a device for measuring an inside diameter of an air passageway.
  • the device includes means for placing an expandable member in the air passageway, the expandable member changeable in a transverse dimension and having a known relationship between volume and changeable transverse dimension, means for changing the changeable transverse dimension to a known transverse dimension, and means for determining that the known transverse dimension is adjacent to opposing portions of an inner periphery of the air passageway.
  • FIG. 1 is a sectional view of a healthy respiratory system
  • FIG. 2 is a perspective view of the bronchi emphasizing the upper right lung lobe
  • FIG. 3 illustrates a respiratory system suffering from COPD
  • FIG. 4 illustrates an air passageway inside diameter measuring device in accordance with the present invention
  • FIG. 5 illustrates an initial step in measuring an inside diameter of an air passageway at a measuring location with the measuring device of FIG. 4, in accordance with an aspect of the invention
  • FIG. 6 illustrates intermediate step in measuring an inside diameter of an air passageway at measuring location with the measuring device of FIG. 4, in accordance with an aspect of the invention
  • FIG. 7 illustrates a final step in measuring an inside diameter of an air passageway at measuring location with the measuring device of FIG. 4, in accordance with an aspect of the invention.
  • FIG. 8 illustrates an air passageway inside diameter measuring device with a partial cross-section illustrating an integral fluid dispenser, in accordance with the present invention
  • FIG. 9 illustrates an air passageway inside diameter measuring device with a catheter having a plurality of lumens, in accordance with the present invention.
  • FIG. 10 is cross-sectional view of the catheter 310 :
  • FIG. 10 is a cross-sectional view of the catheter of FIG. 9 illustrating the plurality of lumens.
  • FIG. 1 is a sectional view of a healthy respiratory system.
  • the respiratory system 20 resides within the thorax 22 that occupies a space defined by the chest wall 24 and the diaphragm 26 .
  • the respiratory system 20 includes trachea 28 ; left mainstem bronchus 30 and right mainstem bronchus 32 (primary, or first generation); and lobar bronchial branches 34 , 36 , 38 , 40 , and 42 (second generation).
  • FIG. 1 also illustrates segmental branches 44 , 46 , 48 , and 50 (third generation). Additional sub-branches are illustrated in FIG. 2.
  • the respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56 , 58 , and 60 . Each bronchial branch and sub-branch communicates with a different portion of a lung lobe, either the entire lung lobe or a portion thereof.
  • the term “air passageway” is meant to denote either a bronchi or bronchioli, and typically means a bronchial branch of any generation.
  • a characteristic of a healthy respiratory system is the arched or inwardly arcuate diaphragm 26 .
  • the diaphragm 26 straightens to increase the volume of the thorax 22 . This causes a negative pressure within the thorax. The negative pressure within the thorax in turn causes the lung lobes to fill with air.
  • the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax, which in turn causes exhalation of the lung lobes.
  • FIG. 2 is a perspective view of the bronchi emphasizing the upper right lung lobe 56 .
  • FIG. 2 illustrates subsegmental bronchial branches 80 , 82 , 84 , 86 , 88 , and 89 (fourth generation) providing air circulation to superior right lung lobe 56 .
  • the fifth- and sixth-generation bronchial branches are illustrated, but not given reference numbers.
  • each generation has a smaller diameter than its predecessor.
  • the inside diameter of a generation varies depending on the particular bronchial branch, and further varies between individuals.
  • a typical lobar bronchus 42 (third generation) providing air circulation to the upper right lobe 56 has an internal diameter of approximately 1 cm.
  • a typical segmental bronchi 48 (fourth generation) has an internal diameter of approximately 4 to 7 mm.
  • the fifth and sixth generations are each proportionately smaller.
  • the bronchial segments include annular ligaments and irregularly located cartilages that provide structure and resilience. The cartilages become increasingly sparse as the bronchial segments become smaller in diameter. The bronchioles do not have ligaments and cartilages.
  • FIG. 3 illustrates a respiratory system suffering from COPD.
  • the lung lobes 52 , 54 , 56 , 58 , and 60 are enlarged and that the diaphragm 26 is not arched but substantially straight.
  • this individual is incapable of breathing normally by moving diaphragm 26 .
  • this individual in order to create the negative pressure in thorax 22 required for breathing, this individual must move the chest wall outwardly to increase the volume of the thorax. This results in inefficient breathing causing these individuals to breathe rapidly with shallow breaths.
  • bronchial sub-branch obstructing devices are generally employed for treating the apex 66 of the right, upper lung lobe 56 .
  • the insertion of an obstructing member or a plurality of obstructing members treats COPD by deriving the benefits of lung volume reduction surgery without the need of performing the surgery.
  • the intra-bronchial obstructions may be anchored in the air passageway to prevent movement or expulsion. In addition to treating COPD, it is presently contemplated that the intra-bronchial obstructions will be used for other purposes, including delivery of therapeutic substances.
  • the COPD treatment contemplates permanent collapse of a lung portion using at least one intra-bronchial obstruction.
  • the collapse leaves extra volume within the thorax for the diaphragm to assume its arched state for acting upon the remaining healthier lung tissue. This should result in improved pulmonary function due to enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricle filling.
  • the treatment of COPD may include several intra-bronchial obstructing members being inserted in air passageways to form a redundant array.
  • obstructing devices may be deployed in the four, fifth-generation air passageways branching off of the fourth-generation bronchial branches 80 and 82 , redundant obstructing members placed in the fourth-generation bronchial branches 80 and 82 , and another redundant obstructing member placed in the third-generation branch 50 .
  • the physical characteristics of the obstructing devices currently available limit the range of air passageway diameters that a particular device can obstruct.
  • the limiting characteristics include both the range of air passageway diameters that a single device can obstruct, and the range of air passageway diameters that can be engaged by anchors of the obstructing device.
  • Use of anchors can allow the obstructing member to be relatively loosely fitted against the air passageway wall, which may preserve mucociliary transport of mucus and debris out of the collapsed lung portion.
  • obstructing devices are provided in a variety of sizes for the various sizes of air passageways.
  • the present invention supports the use of intra-bronchial obstructing devices by enabling the inside diameter of the air passageway to be measured so that an appropriately sized obstructing device may be selected.
  • the present invention may be used in conjunction with placing any type of obstructing member in an air passageway, including a plug, or a member that allows air passage in one direction but not another.
  • FIG. 4 illustrates an air passageway inside diameter measuring device 100 , in accordance with the present invention.
  • Measuring device 100 includes a fluid dispenser 102 , a fluid 108 , a flexible catheter 110 , stopcocks 111 and 113 , a junction fitting 116 , and an expandable member 120 .
  • the fluid dispenser (illustrated as a syringe 102 ) may be any device known in the art suitable for ejecting a measurable volume of the fluid 108 in amounts necessary to fill the expandable member 120 .
  • the fluid dispenser may be manually, mechanically, or electrically operated, or some combination thereof.
  • the fluid dispenser may include a syringe, a syringe pump, or other piston/cylinder arrangement, or may be a deformable compartment or chamber.
  • the fluid dispenser may be a separate device from the flexible catheter 110 , or may be incorporated into it.
  • the syringe 102 of FIG. 4 includes visually readable gradations 106 that correspond to air passageway diameters, and is illustrated with air passageway diameters ranging between zero and 10 mm.
  • the gradations 106 may reflect any range of anticipated air passageway diameters.
  • the syringe 102 also includes a handle 104 connected to a piston 105 , and arranged such that moving the handle 104 transmits the motion to the piston 105 , and the motion is further transmitted to the fluid 108 .
  • the fluid 108 may be any fluid suitable for use within the human body, such as a saline solution.
  • a gas may be used, but a liquid is preferred to provide ease of use and readability in the syringe 102 .
  • the fluid 108 may include a radiopaque contrast substance, such as diatrizoates and lohexol.
  • the flexible catheter 110 may be any flexible, steerable, elongated tubular member arranged for transoral or transnasal insertion into an air passageway, and may be made from any suitable material known in the art, such as polyethylene.
  • the catheter 110 includes an inflation lumen 112 arranged to be in fluid communication with the syringe 102 .
  • the catheter 110 is also arranged to carry and be in fluid communication with the expandable member 120 .
  • catheter 110 has an external diameter of approximately 2 mm.
  • the catheter 110 may include opaque markings visible under fluoroscopy, such as gold or stainless steel, or other markings visible under other visualization methods.
  • the stopcocks 111 and 113 can be opened and closed by operating handles 115 and 114 respectively.
  • the stopcocks 111 and 113 may be made from any material suitable for extracorporeal use.
  • Tubular member 118 is used to direct any fluid 108 drained from the device 100 .
  • the expandable member (illustrated as expandable balloon 120 ) includes a changeable transverse dimension 126 , an outer periphery 122 of the changeable transverse dimension 126 , and an interior inflatable cavity (not shown).
  • the inflatable balloon 120 is generally arranged for intra-bronchial use, and may be made of any thin, flexible complaint or elastic surgical material suitable for use in air passageways known in the art, such as polyurethane, silicone, and natural latex used for low pressure balloons.
  • the compliant material provides a measurable or determinable relationship between balloon volume and the changeable transverse dimension 124 .
  • Balloon 120 may have any transverse cross-sectional shape that can be expanded adjacent to opposing portions of an air passageway wall.
  • balloon 120 is generally described herein as having a round, expanded cross-section with a generally uniform single transverse dimension
  • the balloon 120 may be any shape having a transverse dimension that can be expanded to contact opposing portions of an interior wall of an air passageway.
  • the balloon 120 may be an ellipsoidal transverse cross-section having a changeable transverse dimension that is expandable adjacent to opposing portions of an interior wall of air passageway 81 .
  • aspects of the invention are described herein using a balloon 120 that expands into a round cross-section having an expanded transverse dimension that is a diameter.
  • the balloon 120 may be carried on the distal end of the catheter 110 , or proximate to the distal end of the catheter 110 .
  • the balloon 120 is illustrated in a partially expanded state.
  • the balloon 120 and the catheter 110 are arranged for transoral placement into an air passageway using minimally invasive methods, such as a working lumen of a bronchoscope.
  • the balloon 120 has a deflated configuration for insertion and passage through a working lumen, and for movement within air passageways.
  • the balloon 120 In its deflated state, the balloon 120 is approximately 10 mm in length and has a collapsed diameter suitable for passage through a working channel of a bronchoscope, which presently is approximately 2-3 mm.
  • the balloon 120 In its expanded state, the balloon 120 should be capable of expanding to more than the anticipated cross-sectional area of the air passageway being measured.
  • the air passageway inside diameters being measured are not expected to exceed 10 mm in diameter, so the balloon 120 may have an maximum expanded diameter of approximately 12 mm. Because the air passageway diameter changes noticeably over a short distance, both the deflated and inflated lengths of the balloon are minimized so that a measurement for a particular location is not affected by the distal narrowing or proximal widening.
  • junction fitting 116 has a single lumen that fluid couples the lumen 112 of catheter 110 to the lumens of stopcocks 111 and 113 .
  • the fluid 108 contained in syringe 102 is fluid coupled to the interior cavity of balloon 120 through the lumen of stopcock 113 and the lumen 112 of catheter 110 .
  • the fluid coupling creates fluid communication between the syringe 102 and the balloon 120 such that, when stopcock 113 is open, any change in the fluid volume of the syringe 102 is inversely translated into a change in the fluid volume of the balloon 120 .
  • the fluid 108 and any air contained in the interior cavity of balloon 120 or lumen 112 may be drained through the lumen of stopcock 111 and out tubular member 118 by moving handle 115 to an open position.
  • the air passageway diameter gradations 106 may be marked in millimeter gradations on the syringe 102 because the compliant material used for the balloon 120 provides a known relationship between the volume of the balloon 120 and its. transverse dimension 124 . The known relationship continues to at least when the balloon 120 is initially expanded adjacent to opposing portions of an interior wall of the air passageway.
  • the gradations 106 may start at “0” or another convenient increment such as 2 mm, and are calibrated to correspond to the transverse dimension of the expanded balloon 120 , and thus the air passageway.
  • a measurable volume of the fluid 108 is ejected from the syringe 102 and forced into the balloon 120 through fluid communication by the lumen 112 of catheter 110 .
  • the transverse dimension 124 of the expanded balloon 120 is known from the volume of the fluid 108 ejected from the syringe 102 .
  • the transverse dimension 124 is known or determined by observing the location of the syringe piston 105 with respect to the gradations 106 .
  • the gradations 106 may be marked in volume gradations, such as milliliters, and a conversion table used to convert volume to transverse dimension 124 .
  • Correlation between volume and transverse dimension 124 for a particular balloon configuration may be established using a test bench.
  • Balloon 120 is expanded in a series of openings with several known diameters, and a correlation is established between the expanded volumes of the test balloon 120 and the several known diameters.
  • the syringe gradations 106 are established correlating the volume of the fluid 108 displaced by movement from the “0” gradation with the known diameter.
  • Each individual measuring device 100 may have its gradations determined on a test bench.
  • the physical parameters of the syringe 102 and the balloon 120 may be standardized, allowing standardized gradation markings 106 .
  • FIG. 5 illustrates an initial step in measuring an inside diameter 126 of an air passageway 81 at a measuring location 128 with the measuring device 100 of FIG. 4, in accordance with an aspect of the invention.
  • the measuring device 100 is provided with its elements fluid coupled together and filled with fluid 108 .
  • the syringe 102 , the lumen 112 , and the collapsed balloon 120 are filled with saline solution as fluid 108 , and any air bubbles in the fluid 108 have been removed.
  • the device 100 may be generally provided with the balloon 120 deflated to a minimum transverse dimension 124 of about 2 mm for insertion and movement, all air bubbles eliminated from the fluid 108 , and the syringe piston 105 aligned with a gradation 106 representing the transverse dimension 124 .
  • inside diameter 126 is illustrated slightly displaced from measuring location 128 . However, it is contemplated that measuring device 100 will measure the inside diameter 126 at the measuring location 128 .
  • An initial step includes transorally placing the distal end of catheter 110 and the balloon 120 into the trachea 28 and steering them into the air passageway 81 of the bronchus 80 to the measuring location 128 .
  • This may be accomplished by any method and/or device known in the art.
  • the catheter 110 may be steered into air passageway 81 by being carried in a working lumen 134 of a bronchoscope 130 ; associated with and then steered by the bronchoscope 130 ; inserted after the bronchoscope 130 is proximate to the measuring location 128 and steered adjacent to the shaft of the bronchoscope 130 ; or steered using imaging/visualization techniques, such as computed tomography or radiography.
  • a distal tip of the bronchoscope 134 has been steered into air passageway 81 for dimensioning.
  • another step includes deploying the balloon 120 and the distal end of the catheter 110 from the working lumen 134 . The deployment may be observed with viewing element 132 of the bronchoscope 130 .
  • a further initial step includes advancing the balloon 120 until its transverse dimension 124 is about a balloon length proximal of the measuring location 128 .
  • FIG. 6 illustrates another step in measuring an inside diameter 126 of an air passageway 81 at measuring location 128 with measuring device 100 of FIG. 4, in accordance with an aspect of the invention.
  • An intermediate step includes expanding the balloon 120 in the air passageway 81 to a first trial transverse dimension of the transverse dimension 124 . The expansion is by opening stopcock 113 and advancing the handle 105 of the syringe 102 to eject a known volume of the fluid 108 into the inflation lumen 112 and correspondingly into the balloon 120 . The ejected volume and resulting first trial transverse dimension are known by the gradations 106 . The endoscopist may select the first trial transverse dimension to be slightly less than an estimated air passageway inside diameter 126 .
  • the endoscopist may estimate an air passageway inside diameter 126 based on the particular bronchial branch diameter to be measured. For example, if the targeted bronchial branch usually has air passageway inside diameter 126 between five and six millimeters, a first trial transverse dimension of four millimeters may be selected. In such a case, the stopcock handle 114 is moved to an open position, and the handle 104 pressed until the plunger 105 aligns with the 4 mm gradient of gradations 106 . The stopcock handle 114 is then moved to a closed position, preventing the compliant characteristic of balloon 120 or contact with the air passageway 81 from forcing fluid 108 back into the syringe 102 .
  • Another step includes advancing the balloon 120 distally within the air passageway 81 until the transverse dimension 124 is proximate to the measuring location 128 .
  • the viewing element 132 is used to visually examine the periphery 122 of the balloon 120 at transverse dimension 124 to determine whether first trial transverse dimension is adjacent to the inside wall of the air passageway 81 .
  • “adjacent” or “adjacency” means closing the space between the periphery 122 of the balloon 120 at transverse dimension 124 and an interior periphery of an interior wall of the air passageway 81 .
  • first trial transverse dimension of 4 mm does not result in the transverse dimension 124 being adjacent to opposing portions of an inner periphery of the air passageway wall 81 . Failure of first trial transverse dimension 124 to achieve adjacency is observed through the viewing element 132 .
  • the endoscopist may select a second trial transverse dimension, which may be 5 mm based on the separation observed between the periphery 122 and the inner periphery of the air passageway wall 81 .
  • FIG. 7 illustrates a final step in measuring an inside diameter 126 of an air passageway 81 at measuring location 128 with measuring device 100 of FIG. 4, in accordance with an aspect of the invention.
  • the balloon 120 is retracted from measuring location 128 by about a balloon 120 length to allow room to change to the second trial transverse dimension, which is 5 mm in the example being illustrated herein.
  • the endoscopist changes the volume of fluid 108 in the balloon 120 in substantially the same manner as the first trial transverse dimension was established. If the first trial transverse dimension had been larger than the inside diameter 126 , the handle 104 would be retracted until the piston 105 aligns with a different second trial transverse dimension.
  • Another step includes re-advancing the balloon 120 distally within the air passageway 81 as before until the transverse dimension 124 is located at the measuring location 128 .
  • the viewing element 132 is used to visually examine the periphery 122 of the balloon 120 at transverse dimension 124 to determine whether second trial transverse dimension 124 is adjacent to the inside wall of the air passageway 81 .
  • FIG. 7 illustrates the transverse dimension 124 adjacent to opposing portions of an inner periphery of the air passageway 81 . If adjacency is not achieved, the endoscopist selects additional trial transverse dimensions and continues as described above until adjacency is achieved.
  • the expanded transverse dimension 124 of the balloon 120 is the same as the inside diameter 126 of the air passageway 81 .
  • adjacency between the periphery 122 of the balloon 120 and the inside wall of the air passageway 81 at measuring location 128 is visually confirmed by observation through the viewing element 132 of the bronchoscope 130 .
  • the diameter 126 at measuring location 128 is read by the alignment of the syringe piston 105 with one or more of the gradations 106 , which would be 5 mm in the example.
  • the changeable transverse dimension 124 is expanded to a point where a portion of its periphery 122 at the measuring location 128 is adjacent to opposing portions of the interior periphery 81 of the interior wall of the air passageway 80 .
  • the measuring device 100 is arranged to allow the balloon 120 to be deflated by opening stopcock 113 and drawing the fluid 108 back into the syringe 102 while the balloon 120 is within the air passageway 81 .
  • the catheter 110 and the deflated balloon 120 may then be steered to another measuring location to measure another air passageway diameter 126 .
  • FIG. 8 illustrates an air passageway inside diameter measuring device 200 with a partial cross-section illustrating an integral fluid dispenser 210 , in accordance with the present invention.
  • Measuring device 200 is structurally, functionally, and operationally similar to measuring device 100 of FIG. 4, except that it includes an integral fluid dispenser 210 instead of an external fluid dispenser.
  • Integral fluid dispenser 210 includes shaft 103 , handle 104 , piston 105 , visually readable gradations 106 , a portion of the proximal portion of lumen 112 , and an index mark or point 107 .
  • the structure for changing the fluid volume of the integral fluid dispenser 210 is formed by the piston 105 and a proximal portion lumen 112 cooperatively acting as a piston/cylinder combination for communicating a measurable volume of fluid 108 into the interior inflatable cavity of balloon 120 .
  • Shaft 103 rigidly couples handle 104 to piston 105 .
  • Gradations 106 are incorporated into shaft 103 , and read by alignment with index point 107 on the proximal end of catheter 110 in substantially the same manner as the gradations 106 of device 100 are read by alignment with the piston 105 .
  • measuring device 200 and fluid dispenser 210 are arranged and function substantially similarly to measuring device 100 and its syringe as described in conjunction with FIGS. 4 - 7 .
  • the piston 105 communicates a measurable fluid volume change with the balloon 120 , which is represented by gradations 106 .
  • FIG. 9 and 10 illustrate an air passageway inside diameter measuring device 300 with a catheter 310 having a plurality of lumens 312 and 314 , in accordance with the present invention.
  • FIG. 10 is a cross-sectional view of the catheter 310 .
  • Measuring device 300 is substantially similar in materials, arrangement, and operation to measuring device 100 .
  • Catheter 310 of measuring device 300 includes two lumens, inflation lumen 312 and purge lumen 314 .
  • Junction fitting 316 has two lumens that individually are in fluid communication with lumens 312 and 314 , one lumen arranged to fluid couple the purge lumen 314 to the stopcock 111 , and the other lumen arranged to fluid couple the inflation lumen 312 to the stopcock 113 .
  • the purge lumen 314 promotes flow of entrapped air out of the syringe 102 , catheter 310 , and the balloon 120 .
  • a source of fluid 108 for purging which may be a syringe similar to the syringe 102 , is fluid coupled to junction fitting 316 and lumen 312 .
  • Stopcocks 111 and 113 are opened by appropriately moving handles 115 and 114 respectively, and fluid 108 is ejected from the syringe and flowed through collapsed balloon 120 to purge air from measuring device 300 . Air and fluid 108 are drained from the measuring device 300 from the lumen of stopcock 111 at tubular member 118 .
  • the presence of the lumen 312 for communicating fluid 108 into the balloon 120 and the lumen 314 for purging air and fluid 108 from the balloon 120 facilitate purging entrapped air from the device 300 .
  • stopcocks 111 and 113 are closed.
  • the purging source of fluid 108 is removed from junction fitting 316 , and syringe 102 is then coupled.
  • Measuring device 300 can then be used to measure the inside diameter of a body lumen as described in conjunction with measuring device 100 .
  • the above description includes embodiments of the invention providing a device and method for measuring an inside diameter of a body lumen, such as an air passageway in conjunction with placing an obstructing or valving device in the air passageway to reduce lung volume.
  • the invention is not so limited. Other embodiments of the invention may be used to measure the inside diameter of an air passageway for placing other types of devices having other treatment objectives. Further, other embodiments of the invention may be used to measure a diameter of any body lumen for any procedure, including preparation for implanting a device or other medical procedure.

Abstract

The invention provides a device for measuring an inside diameter of a body lumen, such as an air passageway. The device includes a flexible catheter having an inflation lumen, a fluid dispenser in fluid communication with the inflation lumen and operable to communicate a measurable fluid volume change with the inflation lumen, and an expandable member in fluid communication with the inflation lumen and having a known relationship between volume and a changeable transverse dimension, the transverse dimension being changeable in response to fluid volume changes of the fluid dispenser and arranged for placement adjacent to opposing portions of an interior wall of the air passageway. The expandable member may be dimensioned for transoral placement into the air passageway, and may comprise a balloon that includes a complaint material.

Description

    BACKGROUND
  • The present invention is generally directed to a device and method for measuring the inside diameter of a body lumen and, more particularly, of air passageways. The present invention is more particularly directed toward measuring an inside diameter of an air passageway by transorally inserting a balloon having a known volume-to-diameter relationship in the air passageway, expanding the balloon with a volume of fluid to a known transverse diameter, and determining that the transverse diameter is adjacent to opposing portions of an interior wall of the air passageway. [0001]
  • Several emerging technologies employ devices placed in the air passageways to diagnose and treat conditions of the lung, conditions of organs and body structures that are in proximity to the lungs, and conditions that are systemic. For example, a treatment for Chronic Obstructive Pulmonary Disease (COPD) involves placing obstructing devices in selected air passageways to collapse lung portions distal of the obstructing devices. The devices are typically placed in air passageways between approximately 4 and 10 mm in diameter. [0002]
  • The performance of intra-bronchial devices may be enhanced by sizing the device to fit the air passageway. However, no method or device presently exists for determining the inside diameter of an air passageway. There is a need in the art for quickly and economically measuring the inside diameter of an air passageway to assist in selecting the size of an obstructing device. [0003]
  • In view of the foregoing, there is a need in the art for a new and improved apparatus and method for measuring the inside diameter of air passageways. [0004]
  • SUMMARY
  • The invention provides a device for measuring an inside diameter of a body lumen, such as an air passageway. The device includes a flexible catheter, and a member carried on a distal tip of the catheter, the member having a known transverse dimension and arranged for placement adjacent to opposing portions of an interior wall of the air passageway. [0005]
  • The invention further provides a device for measuring the diameter of an air passageway. The device includes a flexible catheter having an inflation lumen, a fluid dispenser in fluid communication with the inflation lumen and operable to communicate a measurable fluid volume change with the inflation lumen, and an expandable member in fluid communication with the inflation lumen and having a known relationship between fluid volume and a changeable transverse dimension, the transverse dimension being changeable in response to fluid volume changes of the fluid dispenser and arranged for placement adjacent to opposing portions of an interior wall of the air passageway. The expandable member may include a balloon of compliant material. The expandable member may be dimensioned for transoral placement into the air passageway. The expandable member may have a collapsed configuration for placement in the air passageway and an expanded configuration for measuring a diameter of the air passageway. The expandable member may be arranged to transition from an expanded configuration to a collapsed configuration while in the air passageway, and then to transition from the collapsed configuration to a re-expanded configuration for measuring the diameter of another air passageway. The catheter may include configuration to be steerable within bronchi. The catheter may include an expansion lumen and a purge lumen. The transverse dimension of the expandable member may be arranged to have a maximum transverse dimension of between 3 mm and 12 mm. The fluid dispenser may comprise a syringe or a syringe pump, and may further include gradations corresponding to air passageway diameters. The fluid dispenser may include a piston and a proximal portion of the inflation lumen cooperatively acting as a piston/cylinder combination arranged to communicate a measurable fluid volume change with another portion of the inflation lumen in communication with the expandable member. The fluid communicated to the expandable member may include a radiopaque contrast substance. The expandable member may include a radiopaque contrast marker arranged for visualization of the changeable transverse dimension by fluoroscopy. The catheter may have a distal end, and the expandable member may be carried on the catheter proximal to the distal end. The device may further include a visualization device for observing adjacency of the transverse dimension and opposing portions of the interior wall of the air passageway. The visualization device may include a bronchoscope or a fluoroscope. [0006]
  • The invention still further provides an assembly for measuring an inside diameter of an air passageway. The assembly includes a flexible catheter having an inflation lumen, the inflation lumen being arranged for fluid coupling with a fluid dispenser operable to communicate a measurable fluid volume change with the inflation lumen, and an expandable member in fluid communication with the inflation lumen and having a known relationship between fluid volume and a changeable transverse dimension, the transverse dimension of the expandable member being changeable in response to fluid volume changes of the fluid dispenser and arranged for placement adjacent to opposing portions of an interior wall of the air passageway. The expandable member may be carried on the catheter. The catheter may have a distal end, and the expandable member may be carried proximate to the distal end of the catheter. The expandable member may comprise a complaint material, and may be a balloon. The assembly may further include a visualization device for observing adjacency of the transverse dimension and opposing portions of the interior wall of the air passageway. The visualization device may include a bronchoscope or a fluoroscope. [0007]
  • The invention also provides a method of measuring an air passageway diameter. The method includes the steps of placing a balloon member in the air passageway having a known transverse dimension, and determining that the known transverse dimension is adjacent to opposing portions of an inner periphery of the air passageway. [0008]
  • In accordance with one embodiment, the method includes the steps of placing an expandable member in the air passageway, the expandable member changeable in a transverse dimension and having a known relationship between fluid volume and changeable transverse dimension, changing the changeable transverse dimension of the expandable member to a known transverse dimension by changing the fluid volume of the expandable member, and determining that the known expanded transverse dimension is adjacent to opposing portions of an inner periphery of the air passageway. The method may include the further step of placing a fluid dispenser operable to communicate a measurable fluid volume change into fluid communication with the expandable member, and the step of changing to a known transverse dimension includes the further step of measurably changing the volume of fluid in the expandable member with the fluid dispenser. The fluid dispenser may comprise a syringe. The fluid dispenser may include gradations related to air passageway diameter, and the step of determining air passageway diameter may include the further step of observing the gradations. The step of placing an expandable member in the air passageway may include the further step of transorally placing the expandable member in the air passageway. The step of determining may include the further step of visually observing adjacency, which may include using a visualization device or a fluoroscope. The expandable member may include a radiopaque contrast substance arranged to enhance viewing the changeable transverse dimension, and the step of determining adjacency may use fluoroscopy. The expandable member may include a balloon of compliant material. [0009]
  • The invention further provides a device for measuring an inside diameter of a body lumen is provided. The device includes means for placing an expandable member having a known transverse dimension in the air passageway, and means for determining that the known transverse dimension is adjacent to opposing portions of an inner periphery of the air passageway. [0010]
  • The invention still further provides a device for measuring an inside diameter of an air passageway. The device includes means for placing an expandable member in the air passageway, the expandable member changeable in a transverse dimension and having a known relationship between volume and changeable transverse dimension, means for changing the changeable transverse dimension to a known transverse dimension, and means for determining that the known transverse dimension is adjacent to opposing portions of an inner periphery of the air passageway. [0011]
  • These and various other features as well as advantages which characterize the present invention will be apparent from reading the following detailed description and a review of the associated drawings.[0012]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like referenced numerals identify like elements, and wherein: [0013]
  • FIG. 1 is a sectional view of a healthy respiratory system; [0014]
  • FIG. 2 is a perspective view of the bronchi emphasizing the upper right lung lobe; [0015]
  • FIG. 3 illustrates a respiratory system suffering from COPD; [0016]
  • FIG. 4 illustrates an air passageway inside diameter measuring device in accordance with the present invention; [0017]
  • FIG. 5 illustrates an initial step in measuring an inside diameter of an air passageway at a measuring location with the measuring device of FIG. 4, in accordance with an aspect of the invention; [0018]
  • FIG. 6 illustrates intermediate step in measuring an inside diameter of an air passageway at measuring location with the measuring device of FIG. 4, in accordance with an aspect of the invention; [0019]
  • FIG. 7 illustrates a final step in measuring an inside diameter of an air passageway at measuring location with the measuring device of FIG. 4, in accordance with an aspect of the invention; and [0020]
  • FIG. 8 illustrates an air passageway inside diameter measuring device with a partial cross-section illustrating an integral fluid dispenser, in accordance with the present invention; [0021]
  • FIG. 9 illustrates an air passageway inside diameter measuring device with a catheter having a plurality of lumens, in accordance with the present invention. FIG. 10 is cross-sectional view of the catheter [0022] 310: and
  • FIG. 10 is a cross-sectional view of the catheter of FIG. 9 illustrating the plurality of lumens.[0023]
  • DETAILED DESCRIPTION
  • In the following detailed description of exemplary embodiments of the invention, reference is made to the accompanying drawings, which form a part hereof. The detailed description and the drawings illustrate specific exemplary embodiments by which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention. It is understood that other embodiments may be utilized, and other changes may be made, without departing from the spirit or scope of the present invention. The following detailed description is therefore not to be taken in a limiting sense, and the scope of the present invention is defined only by the appended claims. [0024]
  • Throughout the specification and claims, the following terms take the meanings explicitly associated herein unless the context dictates otherwise. The meaning of “a”, “an”, and “the” include plural references. The meaning of “in” includes “in” and “on.” Referring to the drawings, like numbers indicate like parts throughout the views. The term “coupled” means either a direct connection between the things that are coupled, or an indirect connection through one or more intermediary devices. Additionally, a reference to the singular includes a reference to the plural unless otherwise stated or inconsistent with the disclosure herein. Additionally, the term “fluid” means a substance that has no fixed shape and yields easily to external pressure, such as a gas and especially a liquid. [0025]
  • FIG. 1 is a sectional view of a healthy respiratory system. The [0026] respiratory system 20 resides within the thorax 22 that occupies a space defined by the chest wall 24 and the diaphragm 26.
  • The [0027] respiratory system 20 includes trachea 28; left mainstem bronchus 30 and right mainstem bronchus 32 (primary, or first generation); and lobar bronchial branches 34, 36, 38, 40, and 42 (second generation). FIG. 1 also illustrates segmental branches 44, 46, 48, and 50 (third generation). Additional sub-branches are illustrated in FIG. 2. The respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56, 58, and 60. Each bronchial branch and sub-branch communicates with a different portion of a lung lobe, either the entire lung lobe or a portion thereof. As used herein, the term “air passageway” is meant to denote either a bronchi or bronchioli, and typically means a bronchial branch of any generation.
  • A characteristic of a healthy respiratory system is the arched or inwardly arcuate diaphragm [0028] 26. As the individual inhales, the diaphragm 26 straightens to increase the volume of the thorax 22. This causes a negative pressure within the thorax. The negative pressure within the thorax in turn causes the lung lobes to fill with air. When the individual exhales, the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax, which in turn causes exhalation of the lung lobes.
  • FIG. 2 is a perspective view of the bronchi emphasizing the upper [0029] right lung lobe 56. In addition to the bronchial branches illustrated in FIG. 1, FIG. 2 illustrates subsegmental bronchial branches 80, 82, 84, 86, 88, and 89 (fourth generation) providing air circulation to superior right lung lobe 56. The fifth- and sixth-generation bronchial branches are illustrated, but not given reference numbers.
  • The air passageways branch out, much like the roots of a tree. The bronchial segments branch into six generations or orders, and the bronchioles branch into approximately another three to eight generations or orders. Typically, each generation has a smaller diameter than its predecessor. The inside diameter of a generation varies depending on the particular bronchial branch, and further varies between individuals. For example, a typical lobar bronchus [0030] 42 (third generation) providing air circulation to the upper right lobe 56 has an internal diameter of approximately 1 cm. A typical segmental bronchi 48 (fourth generation) has an internal diameter of approximately 4 to 7 mm. The fifth and sixth generations (no reference numbers) are each proportionately smaller. The bronchial segments include annular ligaments and irregularly located cartilages that provide structure and resilience. The cartilages become increasingly sparse as the bronchial segments become smaller in diameter. The bronchioles do not have ligaments and cartilages.
  • FIG. 3 illustrates a respiratory system suffering from COPD. In contrast to the lobes of FIG. 1, here it may be seen that the [0031] lung lobes 52, 54, 56, 58, and 60 are enlarged and that the diaphragm 26 is not arched but substantially straight. Hence, this individual is incapable of breathing normally by moving diaphragm 26. Instead, in order to create the negative pressure in thorax 22 required for breathing, this individual must move the chest wall outwardly to increase the volume of the thorax. This results in inefficient breathing causing these individuals to breathe rapidly with shallow breaths.
  • It has been found that the apex or segmental portions [0032] 62 and 66 of the upper lung lobes 52 and 56, respectively, are most affected by COPD. Hence, bronchial sub-branch obstructing devices are generally employed for treating the apex 66 of the right, upper lung lobe 56. The insertion of an obstructing member or a plurality of obstructing members treats COPD by deriving the benefits of lung volume reduction surgery without the need of performing the surgery. The intra-bronchial obstructions may be anchored in the air passageway to prevent movement or expulsion. In addition to treating COPD, it is presently contemplated that the intra-bronchial obstructions will be used for other purposes, including delivery of therapeutic substances.
  • The COPD treatment contemplates permanent collapse of a lung portion using at least one intra-bronchial obstruction. The collapse leaves extra volume within the thorax for the diaphragm to assume its arched state for acting upon the remaining healthier lung tissue. This should result in improved pulmonary function due to enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricle filling. The treatment of COPD may include several intra-bronchial obstructing members being inserted in air passageways to form a redundant array. For example, if the volume of apex [0033] 66 of the right, upper lung lobe 56 were to be reduced, obstructing devices may be deployed in the four, fifth-generation air passageways branching off of the fourth-generation bronchial branches 80 and 82, redundant obstructing members placed in the fourth-generation bronchial branches 80 and 82, and another redundant obstructing member placed in the third-generation branch 50.
  • The physical characteristics of the obstructing devices currently available limit the range of air passageway diameters that a particular device can obstruct. The limiting characteristics include both the range of air passageway diameters that a single device can obstruct, and the range of air passageway diameters that can be engaged by anchors of the obstructing device. Use of anchors can allow the obstructing member to be relatively loosely fitted against the air passageway wall, which may preserve mucociliary transport of mucus and debris out of the collapsed lung portion. Thus, obstructing devices are provided in a variety of sizes for the various sizes of air passageways. [0034]
  • The present invention supports the use of intra-bronchial obstructing devices by enabling the inside diameter of the air passageway to be measured so that an appropriately sized obstructing device may be selected. As will be appreciated by those skilled the in art, the present invention may be used in conjunction with placing any type of obstructing member in an air passageway, including a plug, or a member that allows air passage in one direction but not another. [0035]
  • FIG. 4 illustrates an air passageway inside [0036] diameter measuring device 100, in accordance with the present invention. Measuring device 100 includes a fluid dispenser 102, a fluid 108, a flexible catheter 110, stopcocks 111 and 113, a junction fitting 116, and an expandable member 120.
  • The fluid dispenser (illustrated as a syringe [0037] 102) may be any device known in the art suitable for ejecting a measurable volume of the fluid 108 in amounts necessary to fill the expandable member 120. The fluid dispenser may be manually, mechanically, or electrically operated, or some combination thereof. The fluid dispenser may include a syringe, a syringe pump, or other piston/cylinder arrangement, or may be a deformable compartment or chamber. The fluid dispenser may be a separate device from the flexible catheter 110, or may be incorporated into it. The syringe 102 of FIG. 4 includes visually readable gradations 106 that correspond to air passageway diameters, and is illustrated with air passageway diameters ranging between zero and 10 mm. The gradations 106 may reflect any range of anticipated air passageway diameters. The syringe 102 also includes a handle 104 connected to a piston 105, and arranged such that moving the handle 104 transmits the motion to the piston 105, and the motion is further transmitted to the fluid 108.
  • The [0038] fluid 108 may be any fluid suitable for use within the human body, such as a saline solution. A gas may be used, but a liquid is preferred to provide ease of use and readability in the syringe 102. The fluid 108 may include a radiopaque contrast substance, such as diatrizoates and lohexol.
  • The [0039] flexible catheter 110 may be any flexible, steerable, elongated tubular member arranged for transoral or transnasal insertion into an air passageway, and may be made from any suitable material known in the art, such as polyethylene. The catheter 110 includes an inflation lumen 112 arranged to be in fluid communication with the syringe 102. The catheter 110 is also arranged to carry and be in fluid communication with the expandable member 120. In an embodiment, catheter 110 has an external diameter of approximately 2 mm. The catheter 110 may include opaque markings visible under fluoroscopy, such as gold or stainless steel, or other markings visible under other visualization methods.
  • The [0040] stopcocks 111 and 113 can be opened and closed by operating handles 115 and 114 respectively. The stopcocks 111 and 113 may be made from any material suitable for extracorporeal use. Tubular member 118 is used to direct any fluid 108 drained from the device 100.
  • The expandable member (illustrated as expandable balloon [0041] 120) includes a changeable transverse dimension 126, an outer periphery 122 of the changeable transverse dimension 126, and an interior inflatable cavity (not shown). The inflatable balloon 120 is generally arranged for intra-bronchial use, and may be made of any thin, flexible complaint or elastic surgical material suitable for use in air passageways known in the art, such as polyurethane, silicone, and natural latex used for low pressure balloons. The compliant material provides a measurable or determinable relationship between balloon volume and the changeable transverse dimension 124. Balloon 120 may have any transverse cross-sectional shape that can be expanded adjacent to opposing portions of an air passageway wall. For example, while balloon 120 is generally described herein as having a round, expanded cross-section with a generally uniform single transverse dimension, the balloon 120 may be any shape having a transverse dimension that can be expanded to contact opposing portions of an interior wall of an air passageway. For example, the balloon 120 may be an ellipsoidal transverse cross-section having a changeable transverse dimension that is expandable adjacent to opposing portions of an interior wall of air passageway 81. For purposes of clarity, aspects of the invention are described herein using a balloon 120 that expands into a round cross-section having an expanded transverse dimension that is a diameter. However, as stated above, the invention is not so limited. The balloon 120 may be carried on the distal end of the catheter 110, or proximate to the distal end of the catheter 110.
  • In FIG. 4, the [0042] balloon 120 is illustrated in a partially expanded state. The balloon 120 and the catheter 110 are arranged for transoral placement into an air passageway using minimally invasive methods, such as a working lumen of a bronchoscope. The balloon 120 has a deflated configuration for insertion and passage through a working lumen, and for movement within air passageways. In its deflated state, the balloon 120 is approximately 10 mm in length and has a collapsed diameter suitable for passage through a working channel of a bronchoscope, which presently is approximately 2-3 mm. In its expanded state, the balloon 120 should be capable of expanding to more than the anticipated cross-sectional area of the air passageway being measured. Typically, the air passageway inside diameters being measured are not expected to exceed 10 mm in diameter, so the balloon 120 may have an maximum expanded diameter of approximately 12 mm. Because the air passageway diameter changes noticeably over a short distance, both the deflated and inflated lengths of the balloon are minimized so that a measurement for a particular location is not affected by the distal narrowing or proximal widening.
  • Junction fitting [0043] 116 has a single lumen that fluid couples the lumen 112 of catheter 110 to the lumens of stopcocks 111 and 113. The fluid 108 contained in syringe 102 is fluid coupled to the interior cavity of balloon 120 through the lumen of stopcock 113 and the lumen 112 of catheter 110. The fluid coupling creates fluid communication between the syringe 102 and the balloon 120 such that, when stopcock 113 is open, any change in the fluid volume of the syringe 102 is inversely translated into a change in the fluid volume of the balloon 120. The fluid 108 and any air contained in the interior cavity of balloon 120 or lumen 112 may be drained through the lumen of stopcock 111 and out tubular member 118 by moving handle 115 to an open position.
  • The air [0044] passageway diameter gradations 106 may be marked in millimeter gradations on the syringe 102 because the compliant material used for the balloon 120 provides a known relationship between the volume of the balloon 120 and its. transverse dimension 124. The known relationship continues to at least when the balloon 120 is initially expanded adjacent to opposing portions of an interior wall of the air passageway. The gradations 106 may start at “0” or another convenient increment such as 2 mm, and are calibrated to correspond to the transverse dimension of the expanded balloon 120, and thus the air passageway. As the handle 104 is pushed from the starting gradation, a measurable volume of the fluid 108, reflected by the other gradations of the gradations 106, is ejected from the syringe 102 and forced into the balloon 120 through fluid communication by the lumen 112 of catheter 110. Because the relationship between the volume and the changeable transverse dimension of the balloon 120 is known, the transverse dimension 124 of the expanded balloon 120 is known from the volume of the fluid 108 ejected from the syringe 102. The transverse dimension 124 is known or determined by observing the location of the syringe piston 105 with respect to the gradations 106. The gradations 106 may be marked in volume gradations, such as milliliters, and a conversion table used to convert volume to transverse dimension 124.
  • Correlation between volume and [0045] transverse dimension 124 for a particular balloon configuration may be established using a test bench. Balloon 120 is expanded in a series of openings with several known diameters, and a correlation is established between the expanded volumes of the test balloon 120 and the several known diameters. The syringe gradations 106 are established correlating the volume of the fluid 108 displaced by movement from the “0” gradation with the known diameter. Each individual measuring device 100 may have its gradations determined on a test bench. Alternatively, the physical parameters of the syringe 102 and the balloon 120 may be standardized, allowing standardized gradation markings 106.
  • FIG. 5 illustrates an initial step in measuring an [0046] inside diameter 126 of an air passageway 81 at a measuring location 128 with the measuring device 100 of FIG. 4, in accordance with an aspect of the invention. In an embodiment, the measuring device 100 is provided with its elements fluid coupled together and filled with fluid 108. The syringe 102, the lumen 112, and the collapsed balloon 120 are filled with saline solution as fluid 108, and any air bubbles in the fluid 108 have been removed. Further, the device 100 may be generally provided with the balloon 120 deflated to a minimum transverse dimension 124 of about 2 mm for insertion and movement, all air bubbles eliminated from the fluid 108, and the syringe piston 105 aligned with a gradation 106 representing the transverse dimension 124. For clarity, inside diameter 126 is illustrated slightly displaced from measuring location 128. However, it is contemplated that measuring device 100 will measure the inside diameter 126 at the measuring location 128.
  • An initial step includes transorally placing the distal end of [0047] catheter 110 and the balloon 120 into the trachea 28 and steering them into the air passageway 81 of the bronchus 80 to the measuring location 128. This may be accomplished by any method and/or device known in the art. The catheter 110 may be steered into air passageway 81 by being carried in a working lumen 134 of a bronchoscope 130; associated with and then steered by the bronchoscope 130; inserted after the bronchoscope 130 is proximate to the measuring location 128 and steered adjacent to the shaft of the bronchoscope 130; or steered using imaging/visualization techniques, such as computed tomography or radiography.
  • Continuing with FIG. 5, an embodiment is illustrated where a distal tip of the [0048] bronchoscope 134 has been steered into air passageway 81 for dimensioning. Once the distal tip is in proximity to measuring location 128, another step includes deploying the balloon 120 and the distal end of the catheter 110 from the working lumen 134. The deployment may be observed with viewing element 132 of the bronchoscope 130. A further initial step includes advancing the balloon 120 until its transverse dimension 124 is about a balloon length proximal of the measuring location 128.
  • FIG. 6 illustrates another step in measuring an [0049] inside diameter 126 of an air passageway 81 at measuring location 128 with measuring device 100 of FIG. 4, in accordance with an aspect of the invention. An intermediate step includes expanding the balloon 120 in the air passageway 81 to a first trial transverse dimension of the transverse dimension 124. The expansion is by opening stopcock 113 and advancing the handle 105 of the syringe 102 to eject a known volume of the fluid 108 into the inflation lumen 112 and correspondingly into the balloon 120. The ejected volume and resulting first trial transverse dimension are known by the gradations 106. The endoscopist may select the first trial transverse dimension to be slightly less than an estimated air passageway inside diameter 126. The endoscopist may estimate an air passageway inside diameter 126 based on the particular bronchial branch diameter to be measured. For example, if the targeted bronchial branch usually has air passageway inside diameter 126 between five and six millimeters, a first trial transverse dimension of four millimeters may be selected. In such a case, the stopcock handle 114 is moved to an open position, and the handle 104 pressed until the plunger 105 aligns with the 4 mm gradient of gradations 106. The stopcock handle 114 is then moved to a closed position, preventing the compliant characteristic of balloon 120 or contact with the air passageway 81 from forcing fluid 108 back into the syringe 102.
  • Another step includes advancing the [0050] balloon 120 distally within the air passageway 81 until the transverse dimension 124 is proximate to the measuring location 128. The viewing element 132 is used to visually examine the periphery 122 of the balloon 120 at transverse dimension 124 to determine whether first trial transverse dimension is adjacent to the inside wall of the air passageway 81. As used herein, “adjacent” or “adjacency” means closing the space between the periphery 122 of the balloon 120 at transverse dimension 124 and an interior periphery of an interior wall of the air passageway 81. FIG. 6 illustrates a situation where the first trial transverse dimension of 4 mm does not result in the transverse dimension 124 being adjacent to opposing portions of an inner periphery of the air passageway wall 81. Failure of first trial transverse dimension 124 to achieve adjacency is observed through the viewing element 132. The endoscopist may select a second trial transverse dimension, which may be 5 mm based on the separation observed between the periphery 122 and the inner periphery of the air passageway wall 81.
  • FIG. 7 illustrates a final step in measuring an [0051] inside diameter 126 of an air passageway 81 at measuring location 128 with measuring device 100 of FIG. 4, in accordance with an aspect of the invention. The balloon 120 is retracted from measuring location 128 by about a balloon 120 length to allow room to change to the second trial transverse dimension, which is 5 mm in the example being illustrated herein. To change the transverse dimension 124 to the second trial transverse dimension, the endoscopist changes the volume of fluid 108 in the balloon 120 in substantially the same manner as the first trial transverse dimension was established. If the first trial transverse dimension had been larger than the inside diameter 126, the handle 104 would be retracted until the piston 105 aligns with a different second trial transverse dimension.
  • Another step includes re-advancing the [0052] balloon 120 distally within the air passageway 81 as before until the transverse dimension 124 is located at the measuring location 128. The viewing element 132 is used to visually examine the periphery 122 of the balloon 120 at transverse dimension 124 to determine whether second trial transverse dimension 124 is adjacent to the inside wall of the air passageway 81. FIG. 7 illustrates the transverse dimension 124 adjacent to opposing portions of an inner periphery of the air passageway 81. If adjacency is not achieved, the endoscopist selects additional trial transverse dimensions and continues as described above until adjacency is achieved.
  • When the [0053] periphery 122 of transverse dimension 124 is adjacent to an interior periphery 81 of the air passageway 80, the expanded transverse dimension 124 of the balloon 120 is the same as the inside diameter 126 of the air passageway 81. In the embodiment illustrated in FIG. 7, adjacency between the periphery 122 of the balloon 120 and the inside wall of the air passageway 81 at measuring location 128 is visually confirmed by observation through the viewing element 132 of the bronchoscope 130. When adjacency exists, the diameter 126 at measuring location 128 is read by the alignment of the syringe piston 105 with one or more of the gradations 106, which would be 5 mm in the example. When the balloon 120 has an expandable transverse cross-section that is not round, the changeable transverse dimension 124 is expanded to a point where a portion of its periphery 122 at the measuring location 128 is adjacent to opposing portions of the interior periphery 81 of the interior wall of the air passageway 80.
  • After the measurement is taken, the measuring [0054] device 100 is arranged to allow the balloon 120 to be deflated by opening stopcock 113 and drawing the fluid 108 back into the syringe 102 while the balloon 120 is within the air passageway 81. The catheter 110 and the deflated balloon 120 may then be steered to another measuring location to measure another air passageway diameter 126.
  • FIG. 8 illustrates an air passageway inside [0055] diameter measuring device 200 with a partial cross-section illustrating an integral fluid dispenser 210, in accordance with the present invention. Measuring device 200 is structurally, functionally, and operationally similar to measuring device 100 of FIG. 4, except that it includes an integral fluid dispenser 210 instead of an external fluid dispenser.
  • [0056] Integral fluid dispenser 210 includes shaft 103, handle 104, piston 105, visually readable gradations 106, a portion of the proximal portion of lumen 112, and an index mark or point 107. The structure for changing the fluid volume of the integral fluid dispenser 210 is formed by the piston 105 and a proximal portion lumen 112 cooperatively acting as a piston/cylinder combination for communicating a measurable volume of fluid 108 into the interior inflatable cavity of balloon 120. Shaft 103 rigidly couples handle 104 to piston 105. Gradations 106 are incorporated into shaft 103, and read by alignment with index point 107 on the proximal end of catheter 110 in substantially the same manner as the gradations 106 of device 100 are read by alignment with the piston 105.
  • In operation, measuring [0057] device 200 and fluid dispenser 210 are arranged and function substantially similarly to measuring device 100 and its syringe as described in conjunction with FIGS. 4-7. When the handle 104 is advanced, the piston 105 communicates a measurable fluid volume change with the balloon 120, which is represented by gradations 106.
  • FIGS. 9 and 10 illustrate an air passageway inside [0058] diameter measuring device 300 with a catheter 310 having a plurality of lumens 312 and 314, in accordance with the present invention. FIG. 10 is a cross-sectional view of the catheter 310. Measuring device 300 is substantially similar in materials, arrangement, and operation to measuring device 100. Catheter 310 of measuring device 300 includes two lumens, inflation lumen 312 and purge lumen 314. Junction fitting 316 has two lumens that individually are in fluid communication with lumens 312 and 314, one lumen arranged to fluid couple the purge lumen 314 to the stopcock 111, and the other lumen arranged to fluid couple the inflation lumen 312 to the stopcock 113.
  • In operation, the [0059] purge lumen 314 promotes flow of entrapped air out of the syringe 102, catheter 310, and the balloon 120. A source of fluid 108 for purging, which may be a syringe similar to the syringe 102, is fluid coupled to junction fitting 316 and lumen 312. Stopcocks 111 and 113 are opened by appropriately moving handles 115 and 114 respectively, and fluid 108 is ejected from the syringe and flowed through collapsed balloon 120 to purge air from measuring device 300. Air and fluid 108 are drained from the measuring device 300 from the lumen of stopcock 111 at tubular member 118. The presence of the lumen 312 for communicating fluid 108 into the balloon 120 and the lumen 314 for purging air and fluid 108 from the balloon 120 facilitate purging entrapped air from the device 300. Once all air is purged, stopcocks 111 and 113 are closed. The purging source of fluid 108 is removed from junction fitting 316, and syringe 102 is then coupled. Measuring device 300 can then be used to measure the inside diameter of a body lumen as described in conjunction with measuring device 100. The above description includes embodiments of the invention providing a device and method for measuring an inside diameter of a body lumen, such as an air passageway in conjunction with placing an obstructing or valving device in the air passageway to reduce lung volume. However, the invention is not so limited. Other embodiments of the invention may be used to measure the inside diameter of an air passageway for placing other types of devices having other treatment objectives. Further, other embodiments of the invention may be used to measure a diameter of any body lumen for any procedure, including preparation for implanting a device or other medical procedure.
  • Although the present invention has been described in detail with reference to certain preferred embodiments, other embodiments are possible. Therefore, the spirit or scope of the appended claims should not be limited to the description of the embodiments contained herein. It is intended that the invention resides in the claims hereinafter appended. [0060]

Claims (45)

What is claimed is:
1. A device for measuring an inside diameter of a body lumen, the device comprising:
a flexible catheter; and
a member carried on a distal tip of the catheter, the member having a known transverse dimension and arranged for placement adjacent to opposing portions of an interior wall of the body lumen.
2. A device for measuring an inside diameter of an air passageway, the device comprising:
a flexible catheter having an inflation lumen;
a fluid dispenser in fluid communication with the inflation lumen and operable to communicate a measurable fluid volume change with the inflation lumen; and
an expandable member in fluid communication with the inflation lumen and having a known relationship between fluid volume and a changeable transverse dimension, the transverse dimension being changeable in response to fluid volume changes of the fluid dispenser and arranged for placement adjacent to opposing portions of an interior wall of the air passageway.
3. The device of claim 2, wherein the expandable member includes dimensioning for transoral placement into the air passageway.
4. The device of claim 2, wherein the catheter further includes a purge lumen.
5. The device of claim 2, wherein the catheter is adapted to be steerable within bronchi.
6. The device of claim 2, wherein the expandable member comprises a balloon that includes a complaint material.
7. The device of claim 2, wherein the transverse dimension of the expandable member is arranged to have a maximum transverse dimension of between 3 mm and 12 mm.
8. The device of claim 2, wherein the expandable member has a collapsed configuration for placement in the air passageway and an expanded configuration for measuring a diameter of the air passageway.
9. The device of claim 7, wherein the expandable member is arranged to transition from the expanded configuration to the collapsed configuration while in the air passageway, and then to transition from the collapsed configuration to a re-expanded configuration for measuring the diameter of another air passageway.
10. The device of claim 2, wherein the fluid dispenser comprises a syringe.
11. The device of claim 2, wherein the fluid dispenser includes a piston and a proximal portion of the inflation lumen cooperatively acting as a piston/cylinder combination arranged to communicate a measurable fluid volume change with the remainder of the inflation lumen.
12. The device of claim 2, wherein the fluid dispenser comprises a syringe pump.
13. The device of claim 2, wherein the fluid dispenser further comprises gradations corresponding to air passageway diameters.
14. The device of claim 2, wherein fluid communicated to the expandable member includes a radiopaque contrast substance.
15. The device of claim 2, wherein the expandable member includes a radiopaque contrast marker arranged for visualization of the changeable transverse dimension by fluoroscopy.
16. The device of claim 2, wherein the catheter has a distal end, and the expandable member is carried on the catheter proximal to the distal end.
17. The device of claim 2, wherein the expandable member includes a balloon of compliant material.
18. The device of claim 2, further including a visualization device for observing adjacency of the transverse dimension and opposing portions of the interior wall of the air passageway.
19. The device of claim 16, wherein the visualization device includes a bronchoscope.
20. The device of claim 16, wherein the visualization device includes a fluoroscope.
21. A device for measuring an inside diameter of an air passageway, the device comprising:
a flexible catheter having an inflation lumen and a purge lumen;
a fluid dispenser in fluid communication with the inflation lumen and operable to communicate a measurable fluid volume change with the inflation lumen; and
an expandable member in fluid communication with the inflation lumen and having a known relationship between fluid volume and a changeable transverse dimension, the transverse dimension being changeable in response to fluid volume changes of the fluid dispenser and arranged for placement adjacent to opposing portions of an interior wall of the air passageway.
22. The device of claim 21, wherein the expandable member includes dimensioning for transoral placement into the air passageway.
23. An assembly for use in measuring the inside diameter of an air passageway, the assembly comprising:
a flexible catheter having an inflation lumen, the inflation lumen being arranged for fluid coupling with a fluid dispenser operable to communicate a measurable fluid volume change with the inflation lumen; and
an expandable member in fluid communication with the inflation lumen and having a known relationship between fluid volume and a changeable transverse dimension, the transverse dimension of the expandable member being changeable in response to fluid volume changes of the fluid dispenser and arranged for placement adjacent to opposing portions of an interior wall of the air passageway.
24. The assembly of claim 23, wherein the expandable member is carried on the catheter.
25. The assembly of claim 24, wherein the catheter has a distal end, and the expandable member is carried proximate to the distal end of the catheter.
26. The assembly of claim 23, wherein the expandable member comprises a complaint material.
27. The assembly of claim 23, wherein the expandable member includes a balloon of compliant material.
28. The assembly of claim 23, further including a visualization device for observing adjacency of the transverse dimension and opposing portions of the interior wall of the air passageway.
29. The assembly of claim 28, wherein the visualization device includes a bronchoscope.
30. The assembly of claim 28, wherein the visualization device includes a fluoroscope.
31. A method of measuring an inside diameter of a body lumen, the method including the steps of:
placing a member having a known transverse dimension in the body lumen; and
determining that the known transverse dimension is adjacent to opposing portions of an inner periphery of the body lumen.
32. A method of measuring an inside diameter of an air passageway, the method including the steps of:
placing an expandable member in the air passageway, the expandable member changeable in a transverse dimension and having a known relationship between fluid volume and changeable transverse dimension;
changing the changeable transverse dimension of the expandable member to a known transverse dimension by changing the fluid volume of the expandable member; and
determining that the known expanded transverse dimension is adjacent to opposing portions of an inner periphery of the air passageway.
33. The method of claim 32, including the further step of placing a fluid dispenser operable to communicate a measurable fluid volume change into fluid communication with the expandable member, and the step of changing to a known transverse dimension includes the further step of measurably changing the volume of fluid in the expandable member with the fluid dispenser.
34. The method of claim 32, wherein the fluid dispenser comprises a syringe.
35. The method of claim 32, wherein the fluid dispenser comprises gradations related to air passageway diameter, and the step of determining air passageway diameter includes the further step of observing the gradations.
36. The method of claim 32, wherein the step of placing an expandable member in the air passageway includes the further step of transorally placing the expandable member in the air passageway.
37. The method of claim 32, wherein the step of determining includes the further step of visually observing adjacency.
38. The method of claim 37, wherein the step of visually observing adjacency includes using a visualization device
39. The method of claim 38, wherein the visualization device includes a bronchoscope.
40. The method of claim 38, wherein the visualization device includes a fluoroscope.
41. The method of claim 32, wherein the expandable member includes a radiopaque contrast substance arranged to enhance viewing the changeable transverse dimension.
42. The method of claim 32, wherein the expandable member includes a radiopaque contrast substance arranged to enhance viewing the changeable transverse dimension, and further wherein the step of determining adjacency uses fluoroscopy.
43. The method of claim 32, wherein the expandable member includes a balloon of compliant material.
44. A device for measuring an inside diameter of an air passageway, the device comprising:
means for placing a member having a known transverse dimension in the air passageway; and
means for determining that the known transverse dimension is adjacent to opposing portions of an inner periphery of the air passageway.
45. A device for measuring an inside diameter of an air passageway, the device comprising:
means for placing an expandable member in the air passageway, the expandable member changeable in a transverse dimension and having a known relationship between volume and changeable transverse dimension;
means for changing the changeable transverse dimension to a known transverse dimension by changing the volume of the expandable member; and
means for determining that the known transverse dimension is adjacent to opposing portions of an inner periphery of the air passageway.
US10/254,392 2002-07-15 2002-09-24 Device and method for measuring the diameter of an air passageway Abandoned US20040059263A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/254,392 US20040059263A1 (en) 2002-09-24 2002-09-24 Device and method for measuring the diameter of an air passageway
PCT/US2003/021901 WO2004006767A2 (en) 2002-07-15 2003-07-15 Device and method for measuring the diameter of an air passageway
AU2003249202A AU2003249202A1 (en) 2002-07-15 2003-07-15 Device and method for measuring the diameter of an air passageway
US11/260,012 US7476203B2 (en) 2002-09-24 2005-10-26 Device and method for measuring the diameter of an air passageway

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/254,392 US20040059263A1 (en) 2002-09-24 2002-09-24 Device and method for measuring the diameter of an air passageway

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/260,012 Continuation US7476203B2 (en) 2002-09-24 2005-10-26 Device and method for measuring the diameter of an air passageway

Publications (1)

Publication Number Publication Date
US20040059263A1 true US20040059263A1 (en) 2004-03-25

Family

ID=31993358

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/254,392 Abandoned US20040059263A1 (en) 2002-07-15 2002-09-24 Device and method for measuring the diameter of an air passageway
US11/260,012 Expired - Lifetime US7476203B2 (en) 2002-09-24 2005-10-26 Device and method for measuring the diameter of an air passageway

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/260,012 Expired - Lifetime US7476203B2 (en) 2002-09-24 2005-10-26 Device and method for measuring the diameter of an air passageway

Country Status (1)

Country Link
US (2) US20040059263A1 (en)

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040225254A1 (en) * 2003-05-07 2004-11-11 Don Tanaka Localized pleurodesis chemical delivery
US20040237966A1 (en) * 2003-05-29 2004-12-02 Don Tanaka Methods and devices to assist pulmonary decompression
US20040244803A1 (en) * 2003-06-05 2004-12-09 Don Tanaka Intra-thoracic collateral ventilation bypass system
US20050025816A1 (en) * 2003-07-15 2005-02-03 Don Tanaka Methods and devices to accelerate wound healing in thoracic anastomosis applications
US20050288549A1 (en) * 2004-06-14 2005-12-29 Pneumrx, Inc. Guided access to lung tissues
US20050288684A1 (en) * 2004-06-16 2005-12-29 Aronson Nathan A Method of reducing collateral flow in a portion of a lung
US20060009801A1 (en) * 2004-07-08 2006-01-12 Mcgurk Erin Pleural effusion treatment device, method and material
US20060025815A1 (en) * 2004-07-08 2006-02-02 Mcgurk Erin Lung device with sealing features
US20060107961A1 (en) * 2004-11-19 2006-05-25 Don Tanaka Localized pleurodesis evacuation device
US20060118126A1 (en) * 2004-11-19 2006-06-08 Don Tanaka Methods and devices for controlling collateral ventilation
US20060118125A1 (en) * 2004-11-19 2006-06-08 Don Tanaka Pulmonary drug delivery
US20060124126A1 (en) * 2004-12-10 2006-06-15 Don Tanaka Collateral ventilation device with chest tube/evacuation features
US20060167416A1 (en) * 2004-11-23 2006-07-27 Mark Mathis Steerable device for accessing a target site and methods
US20070051372A1 (en) * 2005-08-23 2007-03-08 Don Tanaka Collateral ventilation bypass system with retention features
WO2007036035A1 (en) * 2005-09-27 2007-04-05 Angiometrx Inc. Apparatus and method for determining physiologic characteristics of body lumens
US20070163598A1 (en) * 2006-01-17 2007-07-19 Asia Chang Variable resistance pulmonary ventilation bypass valve
US20070221230A1 (en) * 2006-03-13 2007-09-27 David Thompson Minimally invasive lung volume reduction device and method
US20070270776A1 (en) * 2003-06-03 2007-11-22 Respira, Inc. Lung reduction system
US20080119866A1 (en) * 2002-03-20 2008-05-22 Alferness Clifton A Removable anchored lung volume reduction devices and methods
US20080269565A1 (en) * 2005-04-01 2008-10-30 Welch Allyn, Inc. Vaginal Speculum Apparatus
US20080281151A1 (en) * 2007-05-11 2008-11-13 Portaero, Inc. Pulmonary pleural stabilizer
US20080281433A1 (en) * 2007-05-11 2008-11-13 Portaero, Inc. Methods and devices to create a chemically and/or mechanically localized pleurodesis
US20080283065A1 (en) * 2007-05-15 2008-11-20 Portaero, Inc. Methods and devices to maintain patency of a lumen in parenchymal tissue of the lung
US20080295829A1 (en) * 2007-05-30 2008-12-04 Portaero, Inc. Bridge element for lung implant
US20090099530A1 (en) * 2007-10-12 2009-04-16 Martin Neal Adams Valve loader method, system, and apparatus
US20090178289A1 (en) * 2008-01-15 2009-07-16 Masato Sakai Internal diameter measurement device
US20090205665A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Methods and devices for follow-up care and treatment of a pneumostoma
US20090205641A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US20090292262A1 (en) * 2007-10-12 2009-11-26 Martin Neal Adams Valve loader method, system, and apparatus
US20100010302A1 (en) * 2007-02-26 2010-01-14 Vision-Sciences Inc. Endoscopic reflector
US20100170507A1 (en) * 2009-01-08 2010-07-08 Portaero, Inc. Pneumostoma management device with integrated patency sensor and method
US20100204707A1 (en) * 2009-02-11 2010-08-12 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US7789083B2 (en) 2003-05-20 2010-09-07 Portaero, Inc. Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease
US20100256714A1 (en) * 2003-04-08 2010-10-07 Springmeyer Steven C Bronchoscopic lung volume reduction method
US20100262071A1 (en) * 2006-03-31 2010-10-14 James Kutsko Articulable anchor
US20100286544A1 (en) * 2008-02-19 2010-11-11 Portaero, Inc. Methods and devices for assessment of pneumostoma function
US20100305715A1 (en) * 2009-05-18 2010-12-02 Pneumrx, Inc. Cross-Sectional Modification During Deployment of an Elongate Lung Volume Reduction Device
US7931641B2 (en) 2007-05-11 2011-04-26 Portaero, Inc. Visceral pleura ring connector
US7942931B2 (en) 2002-02-21 2011-05-17 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US8062315B2 (en) 2007-05-17 2011-11-22 Portaero, Inc. Variable parietal/visceral pleural coupling
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US8740921B2 (en) 2006-03-13 2014-06-03 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8795241B2 (en) 2011-05-13 2014-08-05 Spiration, Inc. Deployment catheter
US8974484B2 (en) 2001-09-11 2015-03-10 Spiration, Inc. Removable lung reduction devices, systems, and methods
US8974527B2 (en) 2003-08-08 2015-03-10 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US20150272423A1 (en) * 2013-03-27 2015-10-01 Olympus Corporation Endoscope system
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US20170224301A1 (en) * 2016-02-05 2017-08-10 Pulmonx Corporation Methods, systems, and devices for analyzing lung imaging data
EP2273921B1 (en) * 2008-04-09 2018-10-03 Flip Technologies Limited A system for inflating an inflatable element with a liquid inflating medium and a balloon catheter inflated by the system
US20190053906A1 (en) * 2016-03-25 2019-02-21 SPIRATION, INC., d/b/a OLYMPUS RESPIRATORY AMERICA Valve planning tool
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060095032A1 (en) * 1999-11-16 2006-05-04 Jerome Jackson Methods and systems for determining physiologic characteristics for treatment of the esophagus
US6592594B2 (en) 2001-10-25 2003-07-15 Spiration, Inc. Bronchial obstruction device deployment system and method
US20030216769A1 (en) 2002-05-17 2003-11-20 Dillard David H. Removable anchored lung volume reduction devices and methods
US20060018528A1 (en) * 2004-04-27 2006-01-26 Northwestern University Imaging, diagnostic, and therapeutic devices and methods of use thereof
US20060085073A1 (en) * 2004-10-18 2006-04-20 Kamshad Raiszadeh Medical device systems for the spine
US20090076439A1 (en) * 2007-09-14 2009-03-19 Dollar Michael L Inflation System for Balloon Catheter
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US10245098B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US9283051B2 (en) 2008-04-29 2016-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US10448989B2 (en) 2009-04-09 2019-10-22 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US9598691B2 (en) 2008-04-29 2017-03-21 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation to create tissue scaffolds
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
AU2009242611A1 (en) * 2008-05-01 2009-11-05 Spiration, Inc. Direct lung sensor systems, methods, and apparatuses
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US8903488B2 (en) 2009-05-28 2014-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
WO2011035144A2 (en) * 2009-09-17 2011-03-24 Broncus Technologies, Inc. System and method for determining airway diameter using endoscope
JP5692088B2 (en) * 2009-11-20 2015-04-01 住友ベークライト株式会社 Inner diameter measuring device
US8425455B2 (en) 2010-03-30 2013-04-23 Angiodynamics, Inc. Bronchial catheter and method of use
US9020229B2 (en) 2011-05-13 2015-04-28 Broncus Medical, Inc. Surgical assistance planning method using lung motion analysis
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
US9119564B2 (en) 2012-09-13 2015-09-01 Cook Medical Technologies Llc Method of sizing internal body structure, and mechanism and system for same
US9888956B2 (en) 2013-01-22 2018-02-13 Angiodynamics, Inc. Integrated pump and generator device and method of use
CN105074728B (en) 2013-08-09 2019-06-25 堃博生物科技(上海)有限公司 Chest fluoroscopic image and corresponding rib cage and vertebra 3-dimensional image Registration of Measuring Data
JP6594901B2 (en) 2014-05-12 2019-10-23 バージニア テック インテレクチュアル プロパティース インコーポレイテッド Selective modulation of intracellular effects of cells using pulsed electric fields
US10722671B2 (en) * 2014-05-19 2020-07-28 Securisyn Medical, Llc Method and apparatus for determining optimal endotracheal tube size
WO2016100325A1 (en) 2014-12-15 2016-06-23 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques

Citations (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US852321A (en) * 1906-04-13 1907-04-30 Richard A Dickson Lawn-mower.
US1151729A (en) * 1915-01-20 1915-08-31 William H Tigerman Truck.
US2140211A (en) * 1936-09-03 1938-12-13 Charles G Shaw Tap sole blank
US2981254A (en) * 1957-11-12 1961-04-25 Edwin G Vanderbilt Apparatus for the gas deflation of an animal's stomach
US3657744A (en) * 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US3788327A (en) * 1971-03-30 1974-01-29 H Donowitz Surgical implant device
US4014318A (en) * 1973-08-20 1977-03-29 Dockum James M Circulatory assist device and system
US4086665A (en) * 1976-12-16 1978-05-02 Thermo Electron Corporation Artificial blood conduit
US4212463A (en) * 1978-02-17 1980-07-15 Pratt Enoch B Humane bleeder arrow
US4250873A (en) * 1977-04-26 1981-02-17 Richard Wolf Gmbh Endoscopes
US4302854A (en) * 1980-06-04 1981-12-01 Runge Thomas M Electrically activated ferromagnetic/diamagnetic vascular shunt for left ventricular assist
US4610256A (en) * 1984-09-25 1986-09-09 Utah Medical Products, Inc. Pressure transducer
US4684363A (en) * 1984-10-31 1987-08-04 American Hospital Supply Corporation Rapidly inflatable balloon catheter and method
US4710192A (en) * 1985-12-30 1987-12-01 Liotta Domingo S Diaphragm and method for occlusion of the descending thoracic aorta
US4732152A (en) * 1984-12-05 1988-03-22 Medinvent S.A. Device for implantation and a method of implantation in a vessel using such device
US4759758A (en) * 1984-12-07 1988-07-26 Shlomo Gabbay Prosthetic heart valve
US4795449A (en) * 1986-08-04 1989-01-03 Hollister Incorporated Female urinary incontinence device
US4808183A (en) * 1980-06-03 1989-02-28 University Of Iowa Research Foundation Voice button prosthesis and method for installing same
US4819664A (en) * 1984-11-15 1989-04-11 Stefano Nazari Device for selective bronchial intubation and separate lung ventilation, particularly during anesthesia, intensive therapy and reanimation
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US4832680A (en) * 1986-07-03 1989-05-23 C.R. Bard, Inc. Apparatus for hypodermically implanting a genitourinary prosthesis
US4846836A (en) * 1988-10-03 1989-07-11 Reich Jonathan D Artificial lower gastrointestinal valve
US4850999A (en) * 1980-05-24 1989-07-25 Institute Fur Textil-Und Faserforschung Of Stuttgart Flexible hollow organ
US4852568A (en) * 1987-02-17 1989-08-01 Kensey Nash Corporation Method and apparatus for sealing an opening in tissue of a living being
US4877025A (en) * 1988-10-06 1989-10-31 Hanson Donald W Tracheostomy tube valve apparatus
US4934999A (en) * 1987-07-28 1990-06-19 Paul Bader Closure for a male urethra
US4968294A (en) * 1989-02-09 1990-11-06 Salama Fouad A Urinary control valve and method of using same
US5061274A (en) * 1989-12-04 1991-10-29 Kensey Nash Corporation Plug device for sealing openings and method of use
US5116564A (en) * 1988-10-11 1992-05-26 Josef Jansen Method of producing a closing member having flexible closing elements, especially a heart valve
US5116360A (en) * 1990-12-27 1992-05-26 Corvita Corporation Mesh composite graft
US5123919A (en) * 1991-11-21 1992-06-23 Carbomedics, Inc. Combined prosthetic aortic heart valve and vascular graft
US5135488A (en) * 1989-03-17 1992-08-04 Merit Medical Systems, Inc. System and method for monitoring, displaying and recording balloon catheter inflation data
US5151105A (en) * 1991-10-07 1992-09-29 Kwan Gett Clifford Collapsible vessel sleeve implant
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US5171299A (en) * 1991-08-02 1992-12-15 Baxter International Inc. Balloon catheter inflation pressure and diameter display apparatus and method
US5275169A (en) * 1992-01-15 1994-01-04 Innovation Associates Apparatus and method for determining physiologic characteristics of body lumens
US5306234A (en) * 1993-03-23 1994-04-26 Johnson W Dudley Method for closing an atrial appendage
US5342298A (en) * 1992-07-31 1994-08-30 Advanced Cardiovascular Systems, Inc. Automated fluid pressure control system
US5352240A (en) * 1989-05-31 1994-10-04 Promedica International, Inc. Human heart valve replacement with porcine pulmonary valve
US5358518A (en) * 1991-06-25 1994-10-25 Sante Camilli Artificial venous valve
US5366478A (en) * 1993-07-27 1994-11-22 Ethicon, Inc. Endoscopic surgical sealing device
US5382261A (en) * 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5392775A (en) * 1994-03-22 1995-02-28 Adkins, Jr.; Claude N. Duckbill valve for a tracheostomy tube that permits speech
US5409019A (en) * 1992-10-30 1995-04-25 Wilk; Peter J. Coronary artery by-pass method
US5411552A (en) * 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5411507A (en) * 1993-01-08 1995-05-02 Richard Wolf Gmbh Instrument for implanting and extracting stents
US5413599A (en) * 1988-09-20 1995-05-09 Nippon Zeon Co., Ltd. Medical valve apparatus
US5417226A (en) * 1994-06-09 1995-05-23 Juma; Saad Female anti-incontinence device
US5445626A (en) * 1991-12-05 1995-08-29 Gigante; Luigi Valve operated catheter for urinary incontinence and retention
US5486154A (en) * 1993-06-08 1996-01-23 Kelleher; Brian S. Endoscope
US5500014A (en) * 1989-05-31 1996-03-19 Baxter International Inc. Biological valvular prothesis
US5499995A (en) * 1994-05-25 1996-03-19 Teirstein; Paul S. Body passageway closure apparatus and method of use
US5549628A (en) * 1994-02-10 1996-08-27 Bio-Vascular, Inc. Soft tissue stapling buttress
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
US5645565A (en) * 1995-06-13 1997-07-08 Ethicon Endo-Surgery, Inc. Surgical plug
US5660175A (en) * 1995-08-21 1997-08-26 Dayal; Bimal Endotracheal device
US5662713A (en) * 1991-10-09 1997-09-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5683451A (en) * 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
US5693089A (en) * 1995-04-12 1997-12-02 Inoue; Kanji Method of collapsing an implantable appliance
US5697968A (en) * 1995-08-10 1997-12-16 Aeroquip Corporation Check valve for intraluminal graft
US5702409A (en) * 1995-07-21 1997-12-30 W. L. Gore & Associates, Inc. Device and method for reinforcing surgical staples
US5725519A (en) * 1996-09-30 1998-03-10 Medtronic Instent Israel Ltd. Stent loading device for a balloon catheter
US5752965A (en) * 1996-10-21 1998-05-19 Bio-Vascular, Inc. Apparatus and method for producing a reinforced surgical fastener suture line
US5752522A (en) * 1995-05-04 1998-05-19 Cardiovascular Concepts, Inc. Lesion diameter measurement catheter and method
US5800339A (en) * 1989-02-09 1998-09-01 Opticon Medical Inc. Urinary control valve
US5840081A (en) * 1990-05-18 1998-11-24 Andersen; Henning Rud System and method for implanting cardiac valves
US5855597A (en) * 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US5855587A (en) * 1996-06-13 1999-01-05 Chon-Ik Hyon Hole forming device for pierced earrings
US5944738A (en) * 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
US5947997A (en) * 1992-11-25 1999-09-07 William Cook Europe A/S Closure prothesis for transcatheter placement
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US5972009A (en) * 1998-04-07 1999-10-26 Boston Scientific Corporation Ligating band with rounded edges and method of use of same
US5976174A (en) * 1997-12-15 1999-11-02 Ruiz; Carlos E. Medical hole closure device and methods of use
US5976158A (en) * 1997-06-02 1999-11-02 Boston Scientific Corporation Method of using a textured ligating band
US5984965A (en) * 1997-08-28 1999-11-16 Urosurge, Inc. Anti-reflux reinforced stent
US6003517A (en) * 1998-04-30 1999-12-21 Ethicon Endo-Surgery, Inc. Method for using an electrosurgical device on lung tissue
US6007575A (en) * 1997-06-06 1999-12-28 Samuels; Shaun Laurence Wilkie Inflatable intraluminal stent and method for affixing same within the human body
US6009614A (en) * 1998-04-21 2000-01-04 Advanced Cardiovascular Systems, Inc. Stent crimping tool and method of use
US6020380A (en) * 1998-11-25 2000-02-01 Tap Holdings Inc. Method of treating chronic obstructive pulmonary disease
US6027525A (en) * 1996-05-23 2000-02-22 Samsung Electronics., Ltd. Flexible self-expandable stent and method for making the same
US6045560A (en) * 1993-10-06 2000-04-04 United States Surgical Corporation Surgical stapling apparatus with biocompatible surgical fabric
US6146357A (en) * 1999-05-07 2000-11-14 Embol-X, Inc. Balloon occlusion diameter and pressure measuring devices and methods of use
US6174307B1 (en) * 1996-03-29 2001-01-16 Eclipse Surgical Technologies, Inc. Viewing surgical scope for minimally invasive procedures
US6241678B1 (en) * 1998-08-21 2001-06-05 Aga Medical Corporation Sizing catheter for measuring septal defects
US6258100B1 (en) * 1999-08-24 2001-07-10 Spiration, Inc. Method of reducing lung size
US20010037808A1 (en) * 2000-03-04 2001-11-08 Deem Mark E. Methods and devices for use in performing pulmonary procedures
US20020112729A1 (en) * 2001-02-21 2002-08-22 Spiration, Inc. Intra-bronchial obstructing device that controls biological interaction with the patient
US20030050648A1 (en) * 2001-09-11 2003-03-13 Spiration, Inc. Removable lung reduction devices, systems, and methods
US20030083671A1 (en) * 2001-10-25 2003-05-01 Spiration, Inc. Bronchial obstruction device deployment system and method
US20030125763A1 (en) * 1990-02-07 2003-07-03 Mcinnes Peter R. Readily exchangeable perfusion dilatation catheter
US20030154988A1 (en) * 2002-02-21 2003-08-21 Spiration, Inc. Intra-bronchial device that provides a medicant intra-bronchially to the patient
US20030158515A1 (en) * 2002-02-21 2003-08-21 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US6629951B2 (en) * 1999-08-05 2003-10-07 Broncus Technologies, Inc. Devices for creating collateral in the lungs
US6629651B1 (en) * 1997-01-10 2003-10-07 Water Pik, Inc. Flexible shower arm assembly
US20040039250A1 (en) * 2002-05-28 2004-02-26 David Tholfsen Guidewire delivery of implantable bronchial isolation devices in accordance with lung treatment

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654027A (en) * 1985-10-30 1987-03-31 Dragan William B Vascular dilating device
US4759449A (en) * 1987-08-10 1988-07-26 Gold Kenneth S Interlocking expandable bookrack
US5174283A (en) * 1989-11-08 1992-12-29 Parker Jeffrey D Blind orolaryngeal and oroesophageal guiding and aiming device
JP3393383B2 (en) * 1992-01-21 2003-04-07 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Septal defect closure device
US5957672A (en) 1993-11-10 1999-09-28 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Blood pump bearing system
US6056744A (en) * 1994-06-24 2000-05-02 Conway Stuart Medical, Inc. Sphincter treatment apparatus
EP0955933B1 (en) * 1995-10-13 2009-08-26 Medtronic Vascular, Inc. A device for interstitial transvascular intervention
JP3690815B2 (en) * 1996-05-20 2005-08-31 メドトロニック パークサージ インコーポレイテッド Small section catheter
SE9602226D0 (en) * 1996-06-05 1996-06-05 Astra Ab Biocompatible glue
US20020077564A1 (en) * 1996-07-29 2002-06-20 Farallon Medsystems, Inc. Thermography catheter
US5782916A (en) * 1996-08-13 1998-07-21 Galt Laboratories, Inc. Device for maintaining urinary continence
US6124663A (en) 1996-12-16 2000-09-26 The Boeing Company Fiber optic connector having a microelectromechanical positioning apparatus and an associated fabrication method
AU6688398A (en) 1997-03-06 1998-09-22 Percusurge, Inc. Intravascular aspiration system
US6083255A (en) * 1997-04-07 2000-07-04 Broncus Technologies, Inc. Bronchial stenter
US6200333B1 (en) * 1997-04-07 2001-03-13 Broncus Technologies, Inc. Bronchial stenter
US6162245A (en) 1997-05-07 2000-12-19 Iowa-India Investments Company Limited Stent valve and stent graft
US6245102B1 (en) * 1997-05-07 2001-06-12 Iowa-India Investments Company Ltd. Stent, stent graft and stent valve
US5954766A (en) * 1997-09-16 1999-09-21 Zadno-Azizi; Gholam-Reza Body fluid flow control device
EP0941713B1 (en) * 1998-03-04 2004-11-03 Schneider (Europe) GmbH Device to insert an endoprosthesis into a catheter shaft
US6099551A (en) * 1998-03-12 2000-08-08 Shelhigh, Inc. Pericardial strip and stapler assembly for dividing and sealing visceral tissues and method of use thereof
US6141855A (en) 1998-04-28 2000-11-07 Advanced Cardiovascular Systems, Inc. Stent crimping tool and method of use
US5974652A (en) * 1998-05-05 1999-11-02 Advanced Cardiovascular Systems, Inc. Method and apparatus for uniformly crimping a stent onto a catheter
US6599311B1 (en) * 1998-06-05 2003-07-29 Broncus Technologies, Inc. Method and assembly for lung volume reduction
US6096027A (en) * 1998-09-30 2000-08-01 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Bag enclosed stent loading apparatus
US6270527B1 (en) * 1998-10-16 2001-08-07 Sulzer Carbomedics Inc. Elastic valve with partially exposed stent
US6051022A (en) * 1998-12-30 2000-04-18 St. Jude Medical, Inc. Bileaflet valve having non-parallel pivot axes
US6206918B1 (en) * 1999-05-12 2001-03-27 Sulzer Carbomedics Inc. Heart valve prosthesis having a pivot design for improving flow characteristics
US6234996B1 (en) * 1999-06-23 2001-05-22 Percusurge, Inc. Integrated inflation/deflation device and method
US7175644B2 (en) * 2001-02-14 2007-02-13 Broncus Technologies, Inc. Devices and methods for maintaining collateral channels in tissue
US6749606B2 (en) * 1999-08-05 2004-06-15 Thomas Keast Devices for creating collateral channels
US6712812B2 (en) * 1999-08-05 2004-03-30 Broncus Technologies, Inc. Devices for creating collateral channels
US6610043B1 (en) * 1999-08-23 2003-08-26 Bistech, Inc. Tissue volume reduction
US6416554B1 (en) * 1999-08-24 2002-07-09 Spiration, Inc. Lung reduction apparatus and method
US6402754B1 (en) * 1999-10-20 2002-06-11 Spiration, Inc. Apparatus for expanding the thorax
US6510846B1 (en) * 1999-12-23 2003-01-28 O'rourke Sam Sealed back pressure breathing device
US6514290B1 (en) * 2000-03-31 2003-02-04 Broncus Technologies, Inc. Lung elastic recoil restoring or tissue compressing device and method
US6568387B2 (en) * 2000-07-19 2003-05-27 University Of Florida Method for treating chronic obstructive pulmonary disorder
JP4602602B2 (en) * 2001-07-19 2010-12-22 オリンパス株式会社 Medical instruments
US20030018327A1 (en) * 2001-07-20 2003-01-23 Csaba Truckai Systems and techniques for lung volume reduction
EP1435833B1 (en) * 2001-09-10 2014-05-21 Pulmonx Apparatus for endobronchial diagnosis
WO2003022134A2 (en) * 2001-09-11 2003-03-20 Pulmonx Methods of endobronchial diagnosis using imaging
US20030127090A1 (en) * 2001-11-14 2003-07-10 Emphasys Medical, Inc. Active pump bronchial implant devices and methods of use thereof

Patent Citations (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US852321A (en) * 1906-04-13 1907-04-30 Richard A Dickson Lawn-mower.
US1151729A (en) * 1915-01-20 1915-08-31 William H Tigerman Truck.
US2140211A (en) * 1936-09-03 1938-12-13 Charles G Shaw Tap sole blank
US2981254A (en) * 1957-11-12 1961-04-25 Edwin G Vanderbilt Apparatus for the gas deflation of an animal's stomach
US3657744A (en) * 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US3788327A (en) * 1971-03-30 1974-01-29 H Donowitz Surgical implant device
US4014318A (en) * 1973-08-20 1977-03-29 Dockum James M Circulatory assist device and system
US4086665A (en) * 1976-12-16 1978-05-02 Thermo Electron Corporation Artificial blood conduit
US4250873A (en) * 1977-04-26 1981-02-17 Richard Wolf Gmbh Endoscopes
US4212463A (en) * 1978-02-17 1980-07-15 Pratt Enoch B Humane bleeder arrow
US4850999A (en) * 1980-05-24 1989-07-25 Institute Fur Textil-Und Faserforschung Of Stuttgart Flexible hollow organ
US4808183A (en) * 1980-06-03 1989-02-28 University Of Iowa Research Foundation Voice button prosthesis and method for installing same
US4302854A (en) * 1980-06-04 1981-12-01 Runge Thomas M Electrically activated ferromagnetic/diamagnetic vascular shunt for left ventricular assist
US4610256B1 (en) * 1984-09-25 1988-06-21
US4610256A (en) * 1984-09-25 1986-09-09 Utah Medical Products, Inc. Pressure transducer
US4684363A (en) * 1984-10-31 1987-08-04 American Hospital Supply Corporation Rapidly inflatable balloon catheter and method
US4819664A (en) * 1984-11-15 1989-04-11 Stefano Nazari Device for selective bronchial intubation and separate lung ventilation, particularly during anesthesia, intensive therapy and reanimation
US4732152A (en) * 1984-12-05 1988-03-22 Medinvent S.A. Device for implantation and a method of implantation in a vessel using such device
US4759758A (en) * 1984-12-07 1988-07-26 Shlomo Gabbay Prosthetic heart valve
US4710192A (en) * 1985-12-30 1987-12-01 Liotta Domingo S Diaphragm and method for occlusion of the descending thoracic aorta
US4832680A (en) * 1986-07-03 1989-05-23 C.R. Bard, Inc. Apparatus for hypodermically implanting a genitourinary prosthesis
US4795449A (en) * 1986-08-04 1989-01-03 Hollister Incorporated Female urinary incontinence device
US4852568A (en) * 1987-02-17 1989-08-01 Kensey Nash Corporation Method and apparatus for sealing an opening in tissue of a living being
US4934999A (en) * 1987-07-28 1990-06-19 Paul Bader Closure for a male urethra
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US5413599A (en) * 1988-09-20 1995-05-09 Nippon Zeon Co., Ltd. Medical valve apparatus
US4846836A (en) * 1988-10-03 1989-07-11 Reich Jonathan D Artificial lower gastrointestinal valve
US4877025A (en) * 1988-10-06 1989-10-31 Hanson Donald W Tracheostomy tube valve apparatus
US5116564A (en) * 1988-10-11 1992-05-26 Josef Jansen Method of producing a closing member having flexible closing elements, especially a heart valve
US5800339A (en) * 1989-02-09 1998-09-01 Opticon Medical Inc. Urinary control valve
US4968294A (en) * 1989-02-09 1990-11-06 Salama Fouad A Urinary control valve and method of using same
US5135488A (en) * 1989-03-17 1992-08-04 Merit Medical Systems, Inc. System and method for monitoring, displaying and recording balloon catheter inflation data
US5352240A (en) * 1989-05-31 1994-10-04 Promedica International, Inc. Human heart valve replacement with porcine pulmonary valve
US5500014A (en) * 1989-05-31 1996-03-19 Baxter International Inc. Biological valvular prothesis
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
US5061274A (en) * 1989-12-04 1991-10-29 Kensey Nash Corporation Plug device for sealing openings and method of use
US20030125763A1 (en) * 1990-02-07 2003-07-03 Mcinnes Peter R. Readily exchangeable perfusion dilatation catheter
US5840081A (en) * 1990-05-18 1998-11-24 Andersen; Henning Rud System and method for implanting cardiac valves
US5411552A (en) * 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5116360A (en) * 1990-12-27 1992-05-26 Corvita Corporation Mesh composite graft
US5358518A (en) * 1991-06-25 1994-10-25 Sante Camilli Artificial venous valve
US5171299A (en) * 1991-08-02 1992-12-15 Baxter International Inc. Balloon catheter inflation pressure and diameter display apparatus and method
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US5151105A (en) * 1991-10-07 1992-09-29 Kwan Gett Clifford Collapsible vessel sleeve implant
US5662713A (en) * 1991-10-09 1997-09-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5123919A (en) * 1991-11-21 1992-06-23 Carbomedics, Inc. Combined prosthetic aortic heart valve and vascular graft
US5445626A (en) * 1991-12-05 1995-08-29 Gigante; Luigi Valve operated catheter for urinary incontinence and retention
US5275169A (en) * 1992-01-15 1994-01-04 Innovation Associates Apparatus and method for determining physiologic characteristics of body lumens
US5342298A (en) * 1992-07-31 1994-08-30 Advanced Cardiovascular Systems, Inc. Automated fluid pressure control system
US5382261A (en) * 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5409019A (en) * 1992-10-30 1995-04-25 Wilk; Peter J. Coronary artery by-pass method
US5947997A (en) * 1992-11-25 1999-09-07 William Cook Europe A/S Closure prothesis for transcatheter placement
US5411507A (en) * 1993-01-08 1995-05-02 Richard Wolf Gmbh Instrument for implanting and extracting stents
US5306234A (en) * 1993-03-23 1994-04-26 Johnson W Dudley Method for closing an atrial appendage
US5486154A (en) * 1993-06-08 1996-01-23 Kelleher; Brian S. Endoscope
US5366478A (en) * 1993-07-27 1994-11-22 Ethicon, Inc. Endoscopic surgical sealing device
US6045560A (en) * 1993-10-06 2000-04-04 United States Surgical Corporation Surgical stapling apparatus with biocompatible surgical fabric
US5549628A (en) * 1994-02-10 1996-08-27 Bio-Vascular, Inc. Soft tissue stapling buttress
US5392775A (en) * 1994-03-22 1995-02-28 Adkins, Jr.; Claude N. Duckbill valve for a tracheostomy tube that permits speech
US5499995A (en) * 1994-05-25 1996-03-19 Teirstein; Paul S. Body passageway closure apparatus and method of use
US5499995C1 (en) * 1994-05-25 2002-03-12 Paul S Teirstein Body passageway closure apparatus and method of use
US5683451A (en) * 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
US5417226A (en) * 1994-06-09 1995-05-23 Juma; Saad Female anti-incontinence device
US5693089A (en) * 1995-04-12 1997-12-02 Inoue; Kanji Method of collapsing an implantable appliance
US6010511A (en) * 1995-05-04 2000-01-04 Murphy; Richard Lesion diameter measurement catheter and method
US5752522A (en) * 1995-05-04 1998-05-19 Cardiovascular Concepts, Inc. Lesion diameter measurement catheter and method
US5645565A (en) * 1995-06-13 1997-07-08 Ethicon Endo-Surgery, Inc. Surgical plug
US5702409A (en) * 1995-07-21 1997-12-30 W. L. Gore & Associates, Inc. Device and method for reinforcing surgical staples
US5697968A (en) * 1995-08-10 1997-12-16 Aeroquip Corporation Check valve for intraluminal graft
US5660175A (en) * 1995-08-21 1997-08-26 Dayal; Bimal Endotracheal device
US6174307B1 (en) * 1996-03-29 2001-01-16 Eclipse Surgical Technologies, Inc. Viewing surgical scope for minimally invasive procedures
US6027525A (en) * 1996-05-23 2000-02-22 Samsung Electronics., Ltd. Flexible self-expandable stent and method for making the same
US5855587A (en) * 1996-06-13 1999-01-05 Chon-Ik Hyon Hole forming device for pierced earrings
US5725519A (en) * 1996-09-30 1998-03-10 Medtronic Instent Israel Ltd. Stent loading device for a balloon catheter
US5752965A (en) * 1996-10-21 1998-05-19 Bio-Vascular, Inc. Apparatus and method for producing a reinforced surgical fastener suture line
US6629651B1 (en) * 1997-01-10 2003-10-07 Water Pik, Inc. Flexible shower arm assembly
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US5855597A (en) * 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US5976158A (en) * 1997-06-02 1999-11-02 Boston Scientific Corporation Method of using a textured ligating band
US6007575A (en) * 1997-06-06 1999-12-28 Samuels; Shaun Laurence Wilkie Inflatable intraluminal stent and method for affixing same within the human body
US5984965A (en) * 1997-08-28 1999-11-16 Urosurge, Inc. Anti-reflux reinforced stent
US5976174A (en) * 1997-12-15 1999-11-02 Ruiz; Carlos E. Medical hole closure device and methods of use
US5944738A (en) * 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
US5972009A (en) * 1998-04-07 1999-10-26 Boston Scientific Corporation Ligating band with rounded edges and method of use of same
US6009614A (en) * 1998-04-21 2000-01-04 Advanced Cardiovascular Systems, Inc. Stent crimping tool and method of use
US6003517A (en) * 1998-04-30 1999-12-21 Ethicon Endo-Surgery, Inc. Method for using an electrosurgical device on lung tissue
US6241678B1 (en) * 1998-08-21 2001-06-05 Aga Medical Corporation Sizing catheter for measuring septal defects
US6020380A (en) * 1998-11-25 2000-02-01 Tap Holdings Inc. Method of treating chronic obstructive pulmonary disease
US6146357A (en) * 1999-05-07 2000-11-14 Embol-X, Inc. Balloon occlusion diameter and pressure measuring devices and methods of use
US6629951B2 (en) * 1999-08-05 2003-10-07 Broncus Technologies, Inc. Devices for creating collateral in the lungs
US6258100B1 (en) * 1999-08-24 2001-07-10 Spiration, Inc. Method of reducing lung size
US6293951B1 (en) * 1999-08-24 2001-09-25 Spiration, Inc. Lung reduction device, system, and method
US20010037808A1 (en) * 2000-03-04 2001-11-08 Deem Mark E. Methods and devices for use in performing pulmonary procedures
US6679264B1 (en) * 2000-03-04 2004-01-20 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US20020112729A1 (en) * 2001-02-21 2002-08-22 Spiration, Inc. Intra-bronchial obstructing device that controls biological interaction with the patient
US20030050648A1 (en) * 2001-09-11 2003-03-13 Spiration, Inc. Removable lung reduction devices, systems, and methods
US6592594B2 (en) * 2001-10-25 2003-07-15 Spiration, Inc. Bronchial obstruction device deployment system and method
US20030083671A1 (en) * 2001-10-25 2003-05-01 Spiration, Inc. Bronchial obstruction device deployment system and method
US20030154988A1 (en) * 2002-02-21 2003-08-21 Spiration, Inc. Intra-bronchial device that provides a medicant intra-bronchially to the patient
US20030158515A1 (en) * 2002-02-21 2003-08-21 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US20040039250A1 (en) * 2002-05-28 2004-02-26 David Tholfsen Guidewire delivery of implantable bronchial isolation devices in accordance with lung treatment

Cited By (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8974484B2 (en) 2001-09-11 2015-03-10 Spiration, Inc. Removable lung reduction devices, systems, and methods
US7942931B2 (en) 2002-02-21 2011-05-17 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US20080119866A1 (en) * 2002-03-20 2008-05-22 Alferness Clifton A Removable anchored lung volume reduction devices and methods
US8926647B2 (en) 2002-03-20 2015-01-06 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US8021385B2 (en) 2002-03-20 2011-09-20 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US8177805B2 (en) 2002-03-20 2012-05-15 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US20100256714A1 (en) * 2003-04-08 2010-10-07 Springmeyer Steven C Bronchoscopic lung volume reduction method
US8079368B2 (en) 2003-04-08 2011-12-20 Spiration, Inc. Bronchoscopic lung volume reduction method
US20040225254A1 (en) * 2003-05-07 2004-11-11 Don Tanaka Localized pleurodesis chemical delivery
US7828789B2 (en) 2003-05-07 2010-11-09 Portaero, Inc. Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis
US7811274B2 (en) 2003-05-07 2010-10-12 Portaero, Inc. Method for treating chronic obstructive pulmonary disease
US8029492B2 (en) 2003-05-07 2011-10-04 Portaero, Inc. Method for treating chronic obstructive pulmonary disease
US20080188809A1 (en) * 2003-05-07 2008-08-07 Portaero, Inc. Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis
US7789083B2 (en) 2003-05-20 2010-09-07 Portaero, Inc. Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease
US20040237966A1 (en) * 2003-05-29 2004-12-02 Don Tanaka Methods and devices to assist pulmonary decompression
US7896008B2 (en) 2003-06-03 2011-03-01 Portaero, Inc. Lung reduction system
US20070270776A1 (en) * 2003-06-03 2007-11-22 Respira, Inc. Lung reduction system
US7753052B2 (en) 2003-06-05 2010-07-13 Portaero, Inc. Intra-thoracic collateral ventilation bypass system
US20040244803A1 (en) * 2003-06-05 2004-12-09 Don Tanaka Intra-thoracic collateral ventilation bypass system
US20050025816A1 (en) * 2003-07-15 2005-02-03 Don Tanaka Methods and devices to accelerate wound healing in thoracic anastomosis applications
US8323230B2 (en) 2003-07-15 2012-12-04 Portaero, Inc. Methods and devices to accelerate wound healing in thoracic anastomosis applications
US7682332B2 (en) 2003-07-15 2010-03-23 Portaero, Inc. Methods to accelerate wound healing in thoracic anastomosis applications
US20100129420A1 (en) * 2003-07-15 2010-05-27 Portaero, Inc. Methods and devices to accelerate wound healing in thoracic anastomosis applications
US9622752B2 (en) 2003-08-08 2017-04-18 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US8974527B2 (en) 2003-08-08 2015-03-10 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US7670282B2 (en) 2004-06-14 2010-03-02 Pneumrx, Inc. Lung access device
US20050288549A1 (en) * 2004-06-14 2005-12-29 Pneumrx, Inc. Guided access to lung tissues
US7775968B2 (en) 2004-06-14 2010-08-17 Pneumrx, Inc. Guided access to lung tissues
US20050288684A1 (en) * 2004-06-16 2005-12-29 Aronson Nathan A Method of reducing collateral flow in a portion of a lung
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
US20060009801A1 (en) * 2004-07-08 2006-01-12 Mcgurk Erin Pleural effusion treatment device, method and material
US7766938B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Pleural effusion treatment device, method and material
US20060025815A1 (en) * 2004-07-08 2006-02-02 Mcgurk Erin Lung device with sealing features
US20060118125A1 (en) * 2004-11-19 2006-06-08 Don Tanaka Pulmonary drug delivery
US8220460B2 (en) 2004-11-19 2012-07-17 Portaero, Inc. Evacuation device and method for creating a localized pleurodesis
US20060107961A1 (en) * 2004-11-19 2006-05-25 Don Tanaka Localized pleurodesis evacuation device
US20060118126A1 (en) * 2004-11-19 2006-06-08 Don Tanaka Methods and devices for controlling collateral ventilation
US9125639B2 (en) 2004-11-23 2015-09-08 Pneumrx, Inc. Steerable device for accessing a target site and methods
US10034999B2 (en) 2004-11-23 2018-07-31 Pneumrx, Inc. Steerable device for accessing a target site and methods
US20060167416A1 (en) * 2004-11-23 2006-07-27 Mark Mathis Steerable device for accessing a target site and methods
US7824366B2 (en) 2004-12-10 2010-11-02 Portaero, Inc. Collateral ventilation device with chest tube/evacuation features and method
US20060124126A1 (en) * 2004-12-10 2006-06-15 Don Tanaka Collateral ventilation device with chest tube/evacuation features
US20080269565A1 (en) * 2005-04-01 2008-10-30 Welch Allyn, Inc. Vaginal Speculum Apparatus
US8104474B2 (en) 2005-08-23 2012-01-31 Portaero, Inc. Collateral ventilation bypass system with retention features
US20070051372A1 (en) * 2005-08-23 2007-03-08 Don Tanaka Collateral ventilation bypass system with retention features
WO2007036035A1 (en) * 2005-09-27 2007-04-05 Angiometrx Inc. Apparatus and method for determining physiologic characteristics of body lumens
US7686013B2 (en) 2006-01-17 2010-03-30 Portaero, Inc. Variable resistance pulmonary ventilation bypass valve
US7726305B2 (en) 2006-01-17 2010-06-01 Portaero, Inc. Variable resistance pulmonary ventilation bypass valve
US20070163598A1 (en) * 2006-01-17 2007-07-19 Asia Chang Variable resistance pulmonary ventilation bypass valve
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US10226257B2 (en) 2006-03-13 2019-03-12 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US20070221230A1 (en) * 2006-03-13 2007-09-27 David Thompson Minimally invasive lung volume reduction device and method
US20090012626A1 (en) * 2006-03-13 2009-01-08 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US20090076622A1 (en) * 2006-03-13 2009-03-19 Pneumrx, Inc. Delivery of Minimally Invasive Lung Volume Reduction Devices
US8932310B2 (en) 2006-03-13 2015-01-13 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US8142455B2 (en) 2006-03-13 2012-03-27 Pneumrx, Inc. Delivery of minimally invasive lung volume reduction devices
US8668707B2 (en) 2006-03-13 2014-03-11 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US9402971B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US9402632B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US9474533B2 (en) 2006-03-13 2016-10-25 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US9782558B2 (en) 2006-03-13 2017-10-10 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US10188397B2 (en) 2006-03-13 2019-01-29 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US8157823B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8740921B2 (en) 2006-03-13 2014-06-03 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8282660B2 (en) 2006-03-13 2012-10-09 Pneumrx, Inc. Minimally invasive lung volume reduction devices, methods, and systems
US9198669B2 (en) 2006-03-31 2015-12-01 Spiration, Inc. Articulable anchor
US20100262071A1 (en) * 2006-03-31 2010-10-14 James Kutsko Articulable anchor
US8454708B2 (en) 2006-03-31 2013-06-04 Spiration, Inc. Articulable anchor
US8647392B2 (en) 2006-03-31 2014-02-11 Spiration, Inc. Articulable anchor
US20100010302A1 (en) * 2007-02-26 2010-01-14 Vision-Sciences Inc. Endoscopic reflector
US20080281151A1 (en) * 2007-05-11 2008-11-13 Portaero, Inc. Pulmonary pleural stabilizer
US7931641B2 (en) 2007-05-11 2011-04-26 Portaero, Inc. Visceral pleura ring connector
US8163034B2 (en) 2007-05-11 2012-04-24 Portaero, Inc. Methods and devices to create a chemically and/or mechanically localized pleurodesis
US20080281433A1 (en) * 2007-05-11 2008-11-13 Portaero, Inc. Methods and devices to create a chemically and/or mechanically localized pleurodesis
US20100147295A1 (en) * 2007-05-15 2010-06-17 Portaero, Inc. Devices and methods to create and maintain the patency of an opening relative to parenchymal tissue of the lung
US20100147294A1 (en) * 2007-05-15 2010-06-17 Portaero, Inc. Devices and methods to maintain the patency of an opening relative to parenchymal tissue of the lung
US20080283065A1 (en) * 2007-05-15 2008-11-20 Portaero, Inc. Methods and devices to maintain patency of a lumen in parenchymal tissue of the lung
US8062315B2 (en) 2007-05-17 2011-11-22 Portaero, Inc. Variable parietal/visceral pleural coupling
US20080295829A1 (en) * 2007-05-30 2008-12-04 Portaero, Inc. Bridge element for lung implant
US8043301B2 (en) 2007-10-12 2011-10-25 Spiration, Inc. Valve loader method, system, and apparatus
US8136230B2 (en) 2007-10-12 2012-03-20 Spiration, Inc. Valve loader method, system, and apparatus
US20090099530A1 (en) * 2007-10-12 2009-04-16 Martin Neal Adams Valve loader method, system, and apparatus
US9326873B2 (en) 2007-10-12 2016-05-03 Spiration, Inc. Valve loader method, system, and apparatus
US20090292262A1 (en) * 2007-10-12 2009-11-26 Martin Neal Adams Valve loader method, system, and apparatus
US20090178289A1 (en) * 2008-01-15 2009-07-16 Masato Sakai Internal diameter measurement device
US7856730B2 (en) 2008-01-15 2010-12-28 Olympus Medical Systems Corp. Internal diameter measurement device
EP2080474A1 (en) * 2008-01-15 2009-07-22 Olympus Medical Systems Corporation Internal diameter measuring device
US20090205651A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20090209924A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US8231581B2 (en) 2008-02-19 2012-07-31 Portaero, Inc. Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US8021320B2 (en) 2008-02-19 2011-09-20 Portaero, Inc. Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma
US8336540B2 (en) 2008-02-19 2012-12-25 Portaero, Inc. Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US8348906B2 (en) 2008-02-19 2013-01-08 Portaero, Inc. Aspirator for pneumostoma management
US8347880B2 (en) 2008-02-19 2013-01-08 Potaero, Inc. Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease
US20090205665A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Methods and devices for follow-up care and treatment of a pneumostoma
US8365722B2 (en) 2008-02-19 2013-02-05 Portaero, Inc. Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8430094B2 (en) 2008-02-19 2013-04-30 Portaero, Inc. Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8453637B2 (en) 2008-02-19 2013-06-04 Portaero, Inc. Pneumostoma management system for treatment of chronic obstructive pulmonary disease
US8453638B2 (en) 2008-02-19 2013-06-04 Portaero, Inc. One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20110118669A1 (en) * 2008-02-19 2011-05-19 Portaero, Inc. Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US8464708B2 (en) 2008-02-19 2013-06-18 Portaero, Inc. Pneumostoma management system having a cosmetic and/or protective cover
US8475389B2 (en) 2008-02-19 2013-07-02 Portaero, Inc. Methods and devices for assessment of pneumostoma function
US8474449B2 (en) 2008-02-19 2013-07-02 Portaero, Inc. Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease
US8491602B2 (en) 2008-02-19 2013-07-23 Portaero, Inc. Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US8506577B2 (en) 2008-02-19 2013-08-13 Portaero, Inc. Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20090209909A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Percutaneous single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20090205644A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Pneumostoma management system for treatment of chronic obstructive pulmonary disease
US7927324B2 (en) 2008-02-19 2011-04-19 Portaero, Inc. Aspirator and method for pneumostoma management
US7909803B2 (en) 2008-02-19 2011-03-22 Portaero, Inc. Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US20090205648A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease
US8252003B2 (en) 2008-02-19 2012-08-28 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US20090205643A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Accelerated two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20100286544A1 (en) * 2008-02-19 2010-11-11 Portaero, Inc. Methods and devices for assessment of pneumostoma function
US20090205645A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Pneumostoma management method for the treatment of chronic obstructive pulmonary disease
US20090205646A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20090205649A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20090205650A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease
US20090209936A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Aspirator and method for pneumostoma management
US20090209971A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US20090205641A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US20090209856A1 (en) * 2008-02-19 2009-08-20 Portaero, Inc. Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
EP2273921B1 (en) * 2008-04-09 2018-10-03 Flip Technologies Limited A system for inflating an inflatable element with a liquid inflating medium and a balloon catheter inflated by the system
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US9173669B2 (en) 2008-09-12 2015-11-03 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US10285707B2 (en) 2008-09-12 2019-05-14 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US9192403B2 (en) 2008-09-12 2015-11-24 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US10058331B2 (en) 2008-09-12 2018-08-28 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US8347881B2 (en) 2009-01-08 2013-01-08 Portaero, Inc. Pneumostoma management device with integrated patency sensor and method
US20100170507A1 (en) * 2009-01-08 2010-07-08 Portaero, Inc. Pneumostoma management device with integrated patency sensor and method
US8518053B2 (en) 2009-02-11 2013-08-27 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US20100204707A1 (en) * 2009-02-11 2010-08-12 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US8721734B2 (en) 2009-05-18 2014-05-13 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US20100305715A1 (en) * 2009-05-18 2010-12-02 Pneumrx, Inc. Cross-Sectional Modification During Deployment of an Elongate Lung Volume Reduction Device
US8795241B2 (en) 2011-05-13 2014-08-05 Spiration, Inc. Deployment catheter
US9516993B2 (en) * 2013-03-27 2016-12-13 Olympus Corporation Endoscope system
US20150272423A1 (en) * 2013-03-27 2015-10-01 Olympus Corporation Endoscope system
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
US20170224301A1 (en) * 2016-02-05 2017-08-10 Pulmonx Corporation Methods, systems, and devices for analyzing lung imaging data
US10869647B2 (en) * 2016-02-05 2020-12-22 Pulmonx Corporation Methods, systems, and devices for analyzing lung imaging data
US20190053906A1 (en) * 2016-03-25 2019-02-21 SPIRATION, INC., d/b/a OLYMPUS RESPIRATORY AMERICA Valve planning tool
US11039926B2 (en) * 2016-03-25 2021-06-22 Spiration, Inc. Valve planning tool
US11826255B2 (en) 2016-03-25 2023-11-28 Gyrus Acmi, Inc. Valve planning tool

Also Published As

Publication number Publication date
US20060155217A1 (en) 2006-07-13
US7476203B2 (en) 2009-01-13

Similar Documents

Publication Publication Date Title
US7476203B2 (en) Device and method for measuring the diameter of an air passageway
US20040010209A1 (en) Device and method for measuring the diameter of an air passageway
US11413045B2 (en) Methods and devices for passive residual lung volume reduction and functional lung volume expansion
US9622752B2 (en) Bronchoscopic repair of air leaks in a lung
Lausberg et al. Bronchial fenestration improves expiratory flow in emphysematous human lungs
US7100616B2 (en) Bronchoscopic lung volume reduction method
US7766895B2 (en) Methods, systems, and kits for lung volume reduction
US20120053485A1 (en) Catheter Having Needle And Expandable Support Member And Methods Of Use
WO2001002042A9 (en) Methods, systems, and kits for lung volume reduction
CN108784763B (en) Curved balloon catheter retracting device and retracting method thereof
US9486240B2 (en) Inflatable instrument for transanal minimal invasive surgery
WO2004006767A2 (en) Device and method for measuring the diameter of an air passageway
CN109044387A (en) A kind of three chamber angiography catheters that can show esophageal lesion
US11883029B2 (en) Methods and devices for passive residual lung volume reduction and functional lung volume expansion
EP2903514B1 (en) Systems for pulmonary diagnosis

Legal Events

Date Code Title Description
AS Assignment

Owner name: SPIRATION, INC., WASHINGTON

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DEVORE, LAURI J.;SIROKMAN, WILLIAM A.;KUTSKO, JAMES M.;AND OTHERS;REEL/FRAME:013332/0008;SIGNING DATES FROM 20020911 TO 20020918

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: GYRUS ACMI, INC., MASSACHUSETTS

Free format text: MERGER;ASSIGNOR:SPIRATION, INC.;REEL/FRAME:052401/0484

Effective date: 20200401